PubMed registered articles post 2006 Institute for Cancer Genetics and Informatics (former known as the Institute for Medical Informatics)

Publications published since 2006 from OUS - Institute for Cancer Genetics and Informatics

437 publications found

Publications 2020

  1. Bindesbøll C, Aas A, Ogmundsdottir MH, Pankiv S, Reine T, Zoncu R, Simonsen A (2020)
    NBEAL1 controls SREBP2 processing and cholesterol metabolism and is a susceptibility locus for coronary artery disease
    Sci Rep, 10 (1), 4528
    DOI 10.1038/s41598-020-61352-0, PubMed 32161285
  2. Blindheim A, Fosså S, Babigumira R, Myklebust TÅ, Haug E, Arum CJ, Andreassen BK (2020)
    T1 bladder cancer in Norway: treatment and survival
    Scand J Urol
    DOI 10.1080/21681805.2020.1803401, PubMed 32783590
  3. Brandal P, Bergfeldt K, Aggerholm-Pedersen N, Bäckström G, Kerna I, Gubanski M, Björnlinger K, Evensen ME, Kuddu M, Pettersson E, Brydøy M, Hellebust TP, Dale E, Valdman A, Weber L, Høyer M (2020)
    A Nordic-Baltic perspective on indications for proton therapy with strategies for identification of proper patients
    Acta Oncol
    DOI 10.1080/0284186X.2020.1817977, PubMed 32902341
  4. Brunetti M, Panagopoulos I, Kostolomov I, Davidson B, Heim S, Micci F (2020)
    Mutation analysis and genomic imbalances of cells found in effusion fluids from patients with ovarian cancer
    Oncol Lett, 20 (3), 2273-2279
    DOI 10.3892/ol.2020.11782, PubMed 32782545
  5. Davidson B, McFadden E, Holth A, Brunetti M, Flørenes VA (2020)
    Death domain-associated protein (DAXX) expression is associated with poor survival in metastatic high-grade serous carcinoma
    Virchows Arch
    DOI 10.1007/s00428-020-02842-4, PubMed 32533344
  6. Dominguez-Valentin M, Sampson JR, Seppälä TT, Ten Broeke SW, Plazzer JP, Nakken S, Engel C, Aretz S, Jenkins MA, Sunde L, Bernstein I, Capella G, Balaguer F, Thomas H, Evans DG, Burn J, Greenblatt M, Hovig E, de Vos Tot Nederveen Cappel WH, Sijmons RH, Bertario L, Tibiletti MG, Cavestro GM, Lindblom A, Della Valle A et al. (2020)
    Correction: Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
    Genet Med, 22 (9), 1569
    DOI 10.1038/s41436-020-0892-4, PubMed 32690931
  7. Ersvaer E, Hveem TS, Vlatkovic L, Brennhovd B, Kleppe A, Tobin KAR, Pradhan M, Cyll K, Waehre H, Kerr DJ, Danielsen HE (2020)
    Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancer
    Int J Cancer, 147 (4), 1228-1234
    DOI 10.1002/ijc.32832, PubMed 31846064
  8. Ferrante L, Opdal SH, Nygård S, Vege Å, Rognum TO (2020)
    Gene expression profile in cases of infectious death in infancy
    Pediatr Res
    DOI 10.1038/s41390-020-0896-4, PubMed 32299088
  9. Fjeldbo CS, Hompland T, Hillestad T, Aarnes EK, Günther CC, Kristensen GB, Malinen E, Lyng H (2020)
    Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity
    EBioMedicine, 57, 102841
    DOI 10.1016/j.ebiom.2020.102841, PubMed 32580139
  10. Gorunova L, Bjerkehagen B, Micci F, Heim S, Panagopoulos I (2020)
    Cytogenetic and Molecular Study of an Adult Sclerosing Rhabdomyosarcoma of the Extremity: MYOD1-mutation and Clonal Evolution
    Cancer Genomics Proteomics, 17 (5), 563-569
    DOI 10.21873/cgp.20212, PubMed 32859634
  11. Hillestad T, Hompland T, Fjeldbo CS, Skingen VE, Salberg UB, Aarnes EK, Nilsen A, Lund KV, Evensen TS, Kristensen GB, Stokke T, Lyng H (2020)
    MRI Distinguishes Tumor Hypoxia Levels of Different Prognostic and Biological Significance in Cervical Cancer
    Cancer Res, 80 (18), 3993-4003
    DOI 10.1158/0008-5472.CAN-20-0950, PubMed 32606004
  12. Jeanmougin M, Håvik AB, Cekaite L, Brandal P, Sveen A, Meling TR, Ågesen TH, Scheie D, Heim S, Lothe RA, Lind GE (2020)
    Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment
    Mol Oncol, 14 (5), 1016-1027
    DOI 10.1002/1878-0261.12668, PubMed 32171051
  13. Jin Y, Saatcioglu F (2020)
    Targeting the Unfolded Protein Response in Hormone-Regulated Cancers
    Trends Cancer, 6 (2), 160-171
    DOI 10.1016/j.trecan.2019.12.001, PubMed 32061305
  14. Kierulf-Vieira KS, Sandberg CJ, Waaler J, Lund K, Skaga E, Saberniak BM, Panagopoulos I, Brandal P, Krauss S, Langmoen IA, Vik-Mo EO (2020)
    A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation
    Cancers (Basel), 12 (6)
    DOI 10.3390/cancers12061630, PubMed 32575464
  15. Liu MS, Zhao H, Xu CX, Xie PB, Wang W, Yang YY, Lee WH, Jin Y, Zhou HQ (2020)
    Clinical significance of EPHX2 deregulation in prostate cancer
    Asian J Androl (in press)
    DOI 10.4103/aja.aja_34_20, PubMed 32687069
  16. Lund KV, Simonsen TG, Kristensen GB, Rofstad EK (2020)
    DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses
    Radiat Oncol, 15 (1), 79
    DOI 10.1186/s13014-020-01526-2, PubMed 32293487
  17. Monk BJ, Grisham RN, Banerjee S, Kalbacher E, Mirza MR, Romero I, Vuylsteke P, Coleman RL, Hilpert F, Oza AM, Westermann A, Oehler MK, Pignata S, Aghajanian C, Colombo N, Drill E, Cibula D, Moore KN, Christy-Bittel J, Del Campo JM, Berger R, Marth C, Sehouli J, O'Malley DM, Churruca C et al. (2020)
    MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum
    J Clin Oncol, JCO2001164 (in press)
    DOI 10.1200/JCO.20.01164, PubMed 32822286
  18. Norell CH, Butler J, Farrell R, Altman A, Bentley J, Cabasag CJ, Cohen PA, Fegan S, Fung-Kee-Fung M, Gourley C, Hacker NF, Hanna L, Høgdall CK, Kristensen G, Kwon J, McNally O, Nelson G, Nordin A, O'Donnell D, Schnack T, Sykes PH, Zotow E, Harrison S (2020)
    Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care
    Int J Gynecol Cancer (in press)
    DOI 10.1136/ijgc-2020-001403, PubMed 32784203
  19. Panagopoulos I, Gorunova L, Andersen K, Lobmaier I, Lund-Iversen M, Micci F, Heim S (2020)
    Fusion of the Lumican (LUM) Gene With the Ubiquitin Specific Peptidase 6 (USP6) Gene in an Aneurysmal Bone Cyst Carrying a t(12;17)(q21;p13) Chromosome Translocation
    Cancer Genomics Proteomics, 17 (5), 555-561
    DOI 10.21873/cgp.20211, PubMed 32859633
  20. Panagopoulos I, Gorunova L, Andersen K, Lund-Iversen M, Lobmaier I, Micci F, Heim S (2020)
    NDRG1-PLAG1 and TRPS1-PLAG1 Fusion Genes in Chondroid Syringoma
    Cancer Genomics Proteomics, 17 (3), 237-248
    DOI 10.21873/cgp.20184, PubMed 32345665
  21. Panagopoulos I, Gorunova L, Andersen K, Tafjord S, Lund-Iversen M, Lobmaier I, Micci F, Heim S (2020)
    Recurrent Fusion of the GRB2 Associated Binding Protein 1 (GAB1) Gene With ABL Proto-oncogene 1 (ABL1) in Benign Pediatric Soft Tissue Tumors
    Cancer Genomics Proteomics, 17 (5), 499-508
    DOI 10.21873/cgp.20206, PubMed 32859628
  22. Panagopoulos I, Gorunova L, Johannsdottir IMR, Andersen K, Holth A, Beiske K, Heim S (2020)
    Chromosome Translocation t(14;21)(q11;q22) Activates Both OLIG1 and OLIG2 in Pediatric T-cell Lymphoblastic Malignancies and May Signify Adverse Prognosis
    Cancer Genomics Proteomics, 17 (1), 41-48
    DOI 10.21873/cgp.20166, PubMed 31882550
  23. Panagopoulos I, Gorunova L, Kostolomov I, Lobmaier I, Bjerkehagen B, Heim S (2020)
    Chronic Expanding Hematoma with a t(11;19)(q13;q13) Chromosomal Translocation
    Anticancer Res, 40 (1), 97-100
    DOI 10.21873/anticanres.13930, PubMed 31892557
  24. Panagopoulos I, Gorunova L, Lobmaier I, Andersen K, Kostolomov I, Lund-Iversen M, Bjerkehagen B, Heim S (2020)
    FOS-ANKH and FOS-RUNX2 Fusion Genes in Osteoblastoma
    Cancer Genomics Proteomics, 17 (2), 161-168
    DOI 10.21873/cgp.20176, PubMed 32108038
  25. Panagopoulos I, Gorunova L, Lobmaier I, Andersen K, Lund-Iversen M, Micci F, Heim S (2020)
    Fusion of the COL4A5 Gene With NR2F2-AS1 in a Hemangioma Carrying a t(X;15)(q22;q26) Chromosomal Translocation
    Cancer Genomics Proteomics, 17 (4), 383-390
    DOI 10.21873/cgp.20197, PubMed 32576583
  26. Panagopoulos I, Gorunova L, Rise TV, Andersen K, Micci F, Heim S (2020)
    An Unbalanced Chromosome Translocation Between 7p22 and 12q13 Leads to ACTB-GLI1 Fusion in Pericytoma
    Anticancer Res, 40 (3), 1239-1245
    DOI 10.21873/anticanres.14065, PubMed 32132020
  27. Skeie M, Nikolaysen F, Chitano Y, Stang E (2020)
    Hsp90 inhibition and co-incubation with pertuzumab induce internalization and degradation of trastuzumab: Implications for use of T-DM1
    J Cell Mol Med
    DOI 10.1111/jcmm.15643, PubMed 32672902
  28. Skrede OJ, De Raedt S, Kleppe A, Hveem TS, Liestøl K, Maddison J, Askautrud HA, Pradhan M, Nesheim JA, Albregtsen F, Farstad IN, Domingo E, Church DN, Nesbakken A, Shepherd NA, Tomlinson I, Kerr R, Novelli M, Kerr DJ, Danielsen HE (2020)
    Deep learning for prediction of colorectal cancer outcome: a discovery and validation study
    Lancet, 395 (10221), 350-360
    DOI 10.1016/S0140-6736(19)32998-8, PubMed 32007170
  29. Stadskleiv K, Stensvold E, Stokka K, Bechensteen AG, Brandal P (2020)
    Neuropsychological functioning in survivors of childhood medulloblastoma/CNS-PNET: The role of secondary medical complications
    Clin Neuropsychol
    DOI 10.1080/13854046.2020.1794045, PubMed 32729777
  30. Stensvold E, Stadskleiv K, Myklebust TÅ, Wesenberg F, Helseth E, Bechensteen AG, Brandal P (2020)
    Unmet rehabilitation needs in 86% of Norwegian paediatric embryonal brain tumour survivors
    Acta Paediatr, 109 (9), 1875-1886
    DOI 10.1111/apa.15188, PubMed 31977119
  31. Vietri M, Schultz SW, Bellanger A, Jones CM, Petersen LI, Raiborg C, Skarpen E, Pedurupillay CRJ, Kjos I, Kip E, Timmer R, Jain A, Collas P, Knorr RL, Grellscheid SN, Kusumaatmaja H, Brech A, Micci F, Stenmark H, Campsteijn C (2020)
    Unrestrained ESCRT-III drives micronuclear catastrophe and chromosome fragmentation
    Nat Cell Biol, 22 (7), 856-867
    DOI 10.1038/s41556-020-0537-5, PubMed 32601372
  32. Zhang T, Li N, Sun C, Jin Y, Sheng X (2020)
    MYC and the unfolded protein response in cancer: synthetic lethal partners in crime?
    EMBO Mol Med, 12 (5), e11845
    DOI 10.15252/emmm.201911845, PubMed 32310340

Publications 2019

  1. Binzer-Panchal A, Hardell E, Viklund B, Ghaderi M, Bosse T, Nucci MR, Lee CH, Hollfelder N, Corcoran P, Gonzalez-Molina J, Moyano-Galceran L, Bell DA, Schoolmeester JK, Måsbäck A, Kristensen GB, Davidson B, Lehti K, Isaksson A, Carlson JW (2019)
    Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular Subtypes
    Clin Cancer Res, 25 (7), 2155-2165
    DOI 10.1158/1078-0432.CCR-18-2792, PubMed 30617134
  2. Bogsrud TV, Londalen A, Brandal P, Leske H, Panagopoulos I, Borghammer P, Bach-Gansmo T (2019)
    18F-Fluciclovine PET/CT in Suspected Residual or Recurrent High-Grade Glioma
    Clin Nucl Med, 44 (8), 605-611
    DOI 10.1097/RLU.0000000000002641, PubMed 31274605
  3. Brunetti M, Agostini A, Staurseth J, Davidson B, Heim S, Micci F (2019)
    Molecular characterization of carcinosarcomas arising in the uterus and ovaries
    Oncotarget, 10 (38), 3614-3624
    DOI 10.18632/oncotarget.26942, PubMed 31217897
  4. Brunetti M, Panagopoulos I, Micci F, Davidson B (2019)
    MGMT promoter methylation is a rare epigenetic change in malignant effusions
    Cytopathology, 31 (1), 12-15
    DOI 10.1111/cyt.12782, PubMed 31808217
  5. Brynildsen J, Petäjä L, Myhre PL, Lyngbakken MN, Nygård S, Stridsberg M, Christensen G, Ottesen AH, Pettilä V, Omland T, Røsjø H (2019)
    Circulating Secretoneurin Concentrations After Cardiac Surgery: Data From the FINNish Acute Kidney Injury Heart Study
    Crit Care Med, 47 (5), e412-e419
    DOI 10.1097/CCM.0000000000003670, PubMed 30730440
  6. Braadland PR, Urbanucci A (2019)
    Chromatin reprogramming as an adaptation mechanism in advanced prostate cancer
    Endocr Relat Cancer, 26 (4), R211-R235
    DOI 10.1530/ERC-18-0579, PubMed 30844748
  7. Dominguez-Valentin M, Sampson JR, Seppälä TT, Ten Broeke SW, Plazzer JP, Nakken S, Engel C, Aretz S, Jenkins MA, Sunde L, Bernstein I, Capella G, Balaguer F, Thomas H, Evans DG, Burn J, Greenblatt M, Hovig E, de Vos Tot Nederveen Cappel WH, Sijmons RH, Bertario L, Tibiletti MG, Cavestro GM, Lindblom A, Della Valle A et al. (2019)
    Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
    Genet Med, 22 (1), 15-25
    DOI 10.1038/s41436-019-0596-9, PubMed 31337882
  8. Ersvær E, Kildal W, Vlatkovic L, Cyll K, Pradhan M, Kleppe A, Hveem TS, Askautrud HA, Novelli M, Wæhre H, Liestøl K, Danielsen HE (2019)
    Prognostic value of mitotic checkpoint protein BUB3, cyclin B1, and pituitary tumor-transforming 1 expression in prostate cancer
    Mod Pathol, 33 (5), 905-915
    DOI 10.1038/s41379-019-0418-2, PubMed 31801961
  9. Glaire MA, Domingo E, Sveen A, Bruun J, Nesbakken A, Nicholson G, Novelli M, Lawson K, Oukrif D, Kildal W, Danielsen HE, Kerr R, Kerr D, Tomlinson I, Lothe RA, Church DN (2019)
    Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage
    Br J Cancer, 121 (6), 474-482
    DOI 10.1038/s41416-019-0540-4, PubMed 31388185
  10. Glaire MA, Domingo E, Sveen A, Bruun J, Nesbakken A, Nicholson G, Novelli M, Lawson K, Oukrif D, Kildal W, Danielsen HE, Kerr R, Kerr D, Tomlinson I, Lothe RA, Church DN (2019)
    Correction: Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage
    Br J Cancer, 121 (9), 807
    DOI 10.1038/s41416-019-0590-7, PubMed 31548598
  11. Itkonen HM, Urbanucci A, Martin SE, Khan A, Mathelier A, Thiede B, Walker S, Mills IG (2019)
    High OGT activity is essential for MYC-driven proliferation of prostate cancer cells
    Theranostics, 9 (8), 2183-2197
    DOI 10.7150/thno.30834, PubMed 31149037
  12. Jha AK, Neupane P, Pradhan M, Sharma KS, Shrestha S, Sigdel PR, Smeland S, Bruland ØS (2019)
    Ewing Sarcoma in Nepal Treated With Combined Chemotherapy and Definitive Radiotherapy
    J Glob Oncol, 5, 1-10
    DOI 10.1200/JGO.19.00015, PubMed 30917070
  13. Jonsson M, Fjeldbo CS, Holm R, Stokke T, Kristensen GB, Lyng H (2019)
    Mitochondrial Function of CKS2 Oncoprotein Links Oxidative Phosphorylation with Cell Division in Chemoradioresistant Cervical Cancer
    Neoplasia, 21 (4), 353-362
    DOI 10.1016/j.neo.2019.01.002, PubMed 30856376
  14. Kanduri C, Bock C, Gundersen S, Hovig E, Sandve GK (2019)
    Colocalization analyses of genomic elements: approaches, recommendations and challenges
    Bioinformatics, 35 (9), 1615-1624
    DOI 10.1093/bioinformatics/bty835, PubMed 30307532
  15. Lee S, Kolset SO, Birkeland KI, Drevon CA, Reine TM (2019)
    Acute exercise increases syndecan-1 and -4 serum concentrations
    Glycoconj J, 36 (2), 113-125
    DOI 10.1007/s10719-019-09869-z, PubMed 30949875
  16. Lund-Andersen C, Nakken S, Nygård S, Fromm B, Aasheim LB, Davidson B, Julsrud L, Abrahamsen TW, Kristensen AT, Dybdahl B, Larsen SG, Hovig E, Flatmark K (2019)
    Integrative genomic analysis of peritoneal malignant mesothelioma: understanding a case with extraordinary chemotherapy response
    Cold Spring Harb Mol Case Stud, 5 (2)
    DOI 10.1101/mcs.a003566, PubMed 30862609
  17. Lund KV, Simonsen TG, Kristensen GB, Rofstad EK (2019)
    Pharmacokinetic analysis of DCE-MRI data of locally advanced cervical carcinoma with the Brix model
    Acta Oncol, 58 (6), 828-837
    DOI 10.1080/0284186X.2019.1580386, PubMed 30810443
  18. Malmström PU, Skaaheim Haug E, Boström PJ, Gudjónsson S, Bjerggaard Jensen J (2019)
    Progress towards a Nordic standard for the investigation of hematuria: 2019
    Scand J Urol, 53 (1), 1-6
    DOI 10.1080/21681805.2018.1555187, PubMed 30636472
  19. Nilsen A, Jonsson M, Aarnes EK, Kristensen GB, Lyng H (2019)
    Reference MicroRNAs for RT-qPCR Assays in Cervical Cancer Patients and Their Application to Studies of HPV16 and Hypoxia Biomarkers
    Transl Oncol, 12 (3), 576-584
    DOI 10.1016/j.tranon.2018.12.010, PubMed 30660934
  20. Njølstad PR, Andreassen OA, Brunak S, Børglum AD, Dillner J, Esko T, Franks PW, Freimer N, Groop L, Heimer H, Hougaard DM, Hovig E, Hveem K, Jalanko A, Kaprio J, Knudsen GP, Melbye M, Metspalu A, Mortensen PB, Palmgren J, Palotie A, Reed W, Stefánsson H, Stitziel NO, Sullivan PF et al. (2019)
    Roadmap for a precision-medicine initiative in the Nordic region
    Nat Genet, 51 (6), 924-930
    DOI 10.1038/s41588-019-0391-1, PubMed 30988515
  21. Panagopoulos I, Gorunova L, Andersen HK, Pedersen TD, Lømo J, Lund-Iversen M, Micci F, Heim S (2019)
    Genetic Characterization of Myoid Hamartoma of the Breast
    Cancer Genomics Proteomics, 16 (6), 563-568
    DOI 10.21873/cgp.20158, PubMed 31659109
  22. Panagopoulos I, Gorunova L, Lobmaier I, Lund-Iversen M, Andersen K, Holth A, Bjerkehagen B, Heim S (2019)
    Fusion of the COL1A1 and FYN Genes in Epithelioid Osteoblastoma
    Cancer Genomics Proteomics, 16 (5), 361-368
    DOI 10.21873/cgp.20141, PubMed 31467230
  23. Panagopoulos I, Gorunova L, Lund-Iversen M, Bassarova A, Heim S (2019)
    Fusion of the Genes PHF1 and TFE3 in Malignant Chondroid Syringoma
    Cancer Genomics Proteomics, 16 (5), 345-351
    DOI 10.21873/cgp.20139, PubMed 31467228
  24. Panagopoulos I, Lobmaier I, Gorunova L, Heim S (2019)
    Fusion of the Genes WWTR1 and FOSB in Pseudomyogenic Hemangioendothelioma
    Cancer Genomics Proteomics, 16 (4), 293-298
    DOI 10.21873/cgp.20134, PubMed 31243110
  25. Pällmann N, Livgård M, Tesikova M, Zeynep Nenseth H, Akkus E, Sikkeland J, Jin Y, Koc D, Kuzu OF, Pradhan M, Danielsen HE, Kahraman N, Mokhlis HM, Ozpolat B, Banerjee PP, Uren A, Fazli L, Rennie PS, Jin Y, Saatcioglu F (2019)
    Regulation of the unfolded protein response through ATF4 and FAM129A in prostate cancer
    Oncogene, 38 (35), 6301-6318
    DOI 10.1038/s41388-019-0879-2, PubMed 31312022
  26. Ree AH, Nygaard V, Russnes HG, Heinrich D, Nygaard V, Johansen C, Bergheim IR, Hovig E, Beiske K, Negård A, Børresen-Dale AL, Flatmark K, Mælandsmo GM (2019)
    Responsiveness to PD-1 Blockade in End-Stage Colon Cancer with Gene Locus 9p24.1 Copy-Number Gain
    Cancer Immunol Res, 7 (5), 701-706
    DOI 10.1158/2326-6066.CIR-18-0777, PubMed 30804006
  27. Reine TM, Lanzalaco F, Kristiansen O, Enget AR, Satchell S, Jenssen TG, Kolset SO (2019)
    Matrix metalloproteinase-9 mediated shedding of syndecan-4 in glomerular endothelial cells
    Microcirculation, 26 (4), e12534
    DOI 10.1111/micc.12534, PubMed 30703289
  28. Sheng X, Nenseth HZ, Qu S, Kuzu OF, Frahnow T, Simon L, Greene S, Zeng Q, Fazli L, Rennie PS, Mills IG, Danielsen H, Theis F, Patterson JB, Jin Y, Saatcioglu F (2019)
    IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling
    Nat Commun, 10 (1), 323
    DOI 10.1038/s41467-018-08152-3, PubMed 30679434
  29. Sikkeland J, Lindstad T, Nenseth HZ, Dezitter X, Qu S, Muhumed RM, Ertunc ME, Gregor MF, Saatcioglu F (2019)
    Inflammation and ER stress differentially regulate STAMP2 expression and localization in adipocytes
    Metabolism, 93, 75-85
    DOI 10.1016/j.metabol.2019.01.014, PubMed 30710574
  30. Steen CB, Leich E, Myklebust JH, Lockmer S, Wise JF, Wahlin BE, Østenstad B, Liestøl K, Kimby E, Rosenwald A, Smeland EB, Holte H, Lingjærde OC, Brodtkorb M (2019)
    A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy
    Haematologica, 104 (10), e460-e464
    DOI 10.3324/haematol.2018.209080, PubMed 30846496
  31. Stensvold E, Myklebust TÅ, Cappelen J, Due-Tønnessen BJ, Due-Tønnessen P, Kepka A, Johannesen TB, Krossnes B, Lundar T, Maric S, Miletic H, Moholdt V, Myrmel KS, Nordberg T, Rydland J, Stokland T, Solem K, Solheim O, Torsvik I, Wikran GC, Zeller B, Wesenberg F, Bechensteen AG, Brandal P (2019)
    Children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor in Norway from 1974 through 2013: Unexplainable regional differences in survival
    Pediatr Blood Cancer, 66 (10), e27910
    DOI 10.1002/pbc.27910, PubMed 31264356
  32. Torkildsen S, Gorunova L, Heim S, Tjønnfjord GE, Spetalen S, Risberg B, Tran HTT, Panagopoulos I (2019)
    Molecular Genetic Characterization of Acute Myeloid Leukemia With Trisomy 4 as the Sole Chromosome Abnormality
    Cancer Genomics Proteomics, 16 (3), 175-178
    DOI 10.21873/cgp.20123, PubMed 31018948
  33. Vergote I, Coens C, Nankivell M, Kristensen GB, Parmar MKB, Ehlen T, Jayson GC, Johnson N, Swart AM, Verheijen R, McCluggage WG, Perren T, Panici PB, Kenter G, Casado A, Mendiola C, Stuart G, Reed NS, Kehoe S, EORTC MRC CHORUS Study Investigators (2019)
    Neoadjuvant Chemotherapy Versus Debulking Surgery in Advanced Tubo-Ovarian Cancers: Pooled Analysis of Individual Patient Data From the EORTC 55971 and CHORUS Trials
    Obstet. Gynecol. Surv., 74 (3), 156-158

Publications 2018

  1. Agostini A, Brunetti M, Davidson B, Göran Tropé C, Heim S, Panagopoulos I, Micci F (2018)
    Identification of novel cyclin gene fusion transcripts in endometrioid ovarian carcinomas
    Int J Cancer, 143 (6), 1379-1387
    DOI 10.1002/ijc.31418, PubMed 29633253
  2. Agostini A, Brunetti M, Davidson B, Tropé CG, Eriksson AGZ, Heim S, Panagopoulos I, Micci F (2018)
    The microRNA miR-192/215 family is upregulated in mucinous ovarian carcinomas
    Sci Rep, 8 (1), 11069
    DOI 10.1038/s41598-018-29332-7, PubMed 30038317
  3. Andreassen BK, Grimsrud TK, Haug ES (2018)
    Bladder cancer survival: Women better off in the long run
    Eur J Cancer, 95, 52-58
    DOI 10.1016/j.ejca.2018.03.001, PubMed 29635144
  4. Batman S, Morgan T, Brunetti M, Strandabø RAU, Micci F, Moffitt M, Pejovic T (2018)
    Primary mediastinal choriocarcinoma in a female patient: Case report and review of the literature
    Gynecol Oncol Rep, 26, 99-101
    DOI 10.1016/j.gore.2018.10.013, PubMed 30456287
  5. Birkeland E, Zhang S, Poduval D, Geisler J, Nakken S, Vodak D, Meza-Zepeda LA, Hovig E, Myklebost O, Knappskog S, Lønning PE (2018)
    Patterns of genomic evolution in advanced melanoma
    Nat Commun, 9 (1), 2665
    DOI 10.1038/s41467-018-05063-1, PubMed 29991680
  6. Brunetti M, Gorunova L, Davidson B, Heim S, Panagopoulos I, Micci F (2018)
    Identification of an EPC2-PHF1 fusion transcript in low-grade endometrial stromal sarcoma
    Oncotarget, 9 (27), 19203-19208
    DOI 10.18632/oncotarget.24969, PubMed 29721194
  7. Brunetti M, Holth A, Panagopoulos I, Staff AC, Micci F, Davidson B (2018)
    Expression and clinical role of the dipeptidyl peptidases DPP8 and DPP9 in ovarian carcinoma
    Virchows Arch, 474 (2), 177-185
    DOI 10.1007/s00428-018-2487-x, PubMed 30467600
  8. Brynildsen J, Petäjä L, Pettilä V, Nygård S, Vaara ST, Linko R, Okkonen M, Hagve TA, Soininen L, Suojaranta-Ylinen R, Lyngbakken MN, Omland T, Røsjø H (2018)
    The predictive value of NT-proBNP and hs-TnT for risk of death in cardiac surgical patients
    Clin Biochem, 53, 65-71
    DOI 10.1016/j.clinbiochem.2018.01.012, PubMed 29371002
  9. Danielsen HE, Hveem TS, Domingo E, Pradhan M, Kleppe A, Syvertsen RA, Kostolomov I, Nesheim JA, Askautrud HA, Nesbakken A, Lothe RA, Svindland A, Shepherd N, Novelli M, Johnstone E, Tomlinson I, Kerr R, Kerr DJ (2018)
    Prognostic markers for colorectal cancer: estimating ploidy and stroma
    Ann Oncol, 29 (3), 616-623
    DOI 10.1093/annonc/mdx794, PubMed 29293881
  10. Domingo E, Camps C, Kaisaki PJ, Parsons MJ, Mouradov D, Pentony MM, Makino S, Palmieri M, Ward RL, Hawkins NJ, Gibbs P, Askautrud H, Oukrif D, Wang H, Wood J, Tomlinson E, Bark Y, Kaur K, Johnstone EC, Palles C, Church DN, Novelli M, Danielsen HE, Sherlock J, Kerr D et al. (2018)
    Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series
    Lancet Gastroenterol Hepatol, 3 (9), 635-643
    DOI 10.1016/S2468-1253(18)30117-1, PubMed 30042065
  11. Dominguez-Valentin M, Evans DGR, Nakken S, Tubeuf H, Vodak D, Ekstrøm PO, Nissen AM, Morak M, Holinski-Feder E, Martins A, Møller P, Hovig E (2018)
    Genetic variants of prospectively demonstrated phenocopies in BRCA1/2 kindreds
    Hered Cancer Clin Pract, 16, 4
    DOI 10.1186/s13053-018-0086-0, PubMed 29371908
  12. Dominguez-Valentin M, Nakken S, Tubeuf H, Vodak D, Ekstrøm PO, Nissen AM, Morak M, Holinski-Feder E, Martins A, Møller P, Hovig E (2018)
    Identification of genetic variants for clinical management of familial colorectal tumors
    BMC Med Genet, 19 (1), 26
    DOI 10.1186/s12881-018-0533-9, PubMed 29458332
  13. Dominguez-Valentin M, Nakken S, Tubeuf H, Vodak D, Ekstrøm PO, Nissen AM, Morak M, Holinski-Feder E, Martins A, Møller P, Hovig E (2018)
    Potentially pathogenic germline CHEK2 c.319+2T>A among multiple early-onset cancer families
    Fam Cancer, 17 (1), 141-153
    DOI 10.1007/s10689-017-0011-0, PubMed 28608266
  14. Ebenesersdóttir SS, Sandoval-Velasco M, Gunnarsdóttir ED, Jagadeesan A, Guðmundsdóttir VB, Thordardóttir EL, Einarsdóttir MS, Moore KHS, Sigurðsson Á, Magnúsdóttir DN, Jónsson H, Snorradóttir S, Hovig E, Møller P, Kockum I, Olsson T, Alfredsson L, Hansen TF, Werge T, Cavalleri GL, Gilbert E, Lalueza-Fox C, Walser JW, Kristjánsdóttir S, Gopalakrishnan S et al. (2018)
    Ancient genomes from Iceland reveal the making of a human population
    Science, 360 (6392), 1028-1032
    DOI 10.1126/science.aar2625, PubMed 29853688
  15. Fusser M, Øverbye A, Pandya AD, Mørch Ý, Borgos SE, Kildal W, Snipstad S, Sulheim E, Fleten KG, Askautrud HA, Engebraaten O, Flatmark K, Iversen TG, Sandvig K, Skotland T, Mælandsmo GM (2018)
    Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft
    J Control Release, 293, 183-192
    DOI 10.1016/j.jconrel.2018.11.029, PubMed 30529259
  16. Georgakopoulos N, Diamantopoulos P, Micci F, Giannakopoulou N, Zervakis K, Dimitrakopoulou A, Viniou NA (2018)
    An Adult Patient with Early Pre-B Acute Lymphoblastic Leukemia with t(12;17)(p13;q21)/ZNF384-TAF15
    In Vivo, 32 (5), 1241-1245
    DOI 10.21873/invivo.11371, PubMed 30150451
  17. Gerhauser C, Favero F, Risch T, Simon R, Feuerbach L, Assenov Y, Heckmann D, Sidiropoulos N, Waszak SM, Hübschmann D, Urbanucci A, Girma EG, Kuryshev V, Klimczak LJ, Saini N, Stütz AM, Weichenhan D, Böttcher LM, Toth R, Hendriksen JD, Koop C, Lutsik P, Matzk S, Warnatz HJ, Amstislavskiy V et al. (2018)
    Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories
    Cancer Cell, 34 (6), 996-1011.e8
    DOI 10.1016/j.ccell.2018.10.016, PubMed 30537516
  18. González Martín A, Oza AM, Embleton AC, Pfisterer J, Ledermann JA, Pujade-Lauraine E, Kristensen G, Bertrand MA, Beale P, Cervantes A, Kent E, Kaplan RS, Parmar MKB, Scotto N, Perren TJ, ICON7 investigators (2018)
    Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer
    Gynecol Oncol, 152 (1), 53-60
    DOI 10.1016/j.ygyno.2018.08.036, PubMed 30449719
  19. Johannessen LE, Brandal P, Myklebust TÅ, Heim S, Micci F, Panagopoulos I (2018)
    MGMT Gene Promoter Methylation Status - Assessment of Two Pyrosequencing Kits and Three Methylation-specific PCR Methods for their Predictive Capacity in Glioblastomas
    Cancer Genomics Proteomics, 15 (6), 437-446
    DOI 10.21873/cgp.20102, PubMed 30343277
  20. Kleppe A, Albregtsen F, Vlatkovic L, Pradhan M, Nielsen B, Hveem TS, Askautrud HA, Kristensen GB, Nesbakken A, Trovik J, Wæhre H, Tomlinson I, Shepherd NA, Novelli M, Kerr DJ, Danielsen HE (2018)
    Chromatin organisation and cancer prognosis: a pan-cancer study
    Lancet Oncol, 19 (3), 356-369
    DOI 10.1016/S1470-2045(17)30899-9, PubMed 29402700
  21. Kleppe A, Danielsen HE (2018)
    Clinical utility of chromatin analysis
    Oncotarget, 9 (65), 32406-32407
    DOI 10.18632/oncotarget.25991, PubMed 30197751
  22. Kumar RP, Barkhatov L, Edwin B, Albregtsen F, Elle OJ (2018)
    Portal and Hepatic Vein Segmentation with Leak Restriction: A Pilot Study
    IFMBE PROC, 65, 823-826
  23. Leske H, Rushing E, Budka H, Niehusmann P, Pahnke J, Panagopoulos I (2018)
    K27/G34 versus K28/G35 in histone H3-mutant gliomas: A note of caution
    Acta Neuropathol, 136 (1), 175-176
    DOI 10.1007/s00401-018-1867-2, PubMed 29766298
  24. Møller P, Hovig E (2018)
    Retraction Note to: The BRCA2 variant c.68-7 T > A is associated with breast cancer
    Hered Cancer Clin Pract, 16, 10
    DOI 10.1186/s13053-018-0093-1, PubMed 29745381
  25. Nielsen B, Kleppe A, Hveem TS, Pradhan M, Syvertsen RA, Nesheim JA, Kristensen GB, Trovik J, Kerr DJ, Albregtsen F, Danielsen HE (2018)
    Association Between Proportion of Nuclei With High Chromatin Entropy and Prognosis in Gynecological Cancers
    J Natl Cancer Inst, 110 (12), 1400-1408
    DOI 10.1093/jnci/djy063, PubMed 29684152
  26. Panagopoulos I, Gorunova L, Andersen HK, Bergrem A, Dahm A, Andersen K, Micci F, Heim S (2018)
    PAN3-PSMA2 fusion resulting from a novel t(7;13)(p14;q12) chromosome translocation in a myelodysplastic syndrome that evolved into acute myeloid leukemia
    Exp Hematol Oncol, 7, 7
    DOI 10.1186/s40164-018-0099-4, PubMed 29560286
  27. Panagopoulos I, Gorunova L, Andersen K, Lobmaier I, Bjerkehagen B, Heim S (2018)
    Consistent Involvement of Chromosome 13 in Angiolipoma
    Cancer Genomics Proteomics, 15 (1), 61-65
    DOI 10.21873/cgp.20065, PubMed 29275363
  28. Panagopoulos I, Gorunova L, Jacobsen EM, Andersen K, Micci F, Heim S (2018)
    RUNX1-PDCD6 fusion resulting from a novel t(5;21)(p15;q22) chromosome translocation in myelodysplastic syndrome secondary to chronic lymphocytic leukemia
    PLoS One, 13 (4), e0196181
    DOI 10.1371/journal.pone.0196181, PubMed 29672642
  29. Panagopoulos I, Gorunova L, Leske H, Niehusmann P, Johannessen LE, Staurseth J, Øino N, Meling TR, Heim S, Micci F, Brandal P (2018)
    Pyrosequencing Analysis of MGMT Promoter Methylation in Meningioma
    Cancer Genomics Proteomics, 15 (5), 379-385
    DOI 10.21873/cgp.20096, PubMed 30194078
  30. Panagopoulos I, Gorunova L, Lund-Iversen M, Andersen K, Andersen HK, Lobmaier I, Bjerkehagen B, Heim S (2018)
    Cytogenetics of Spindle Cell/Pleomorphic Lipomas: Karyotyping and FISH Analysis of 31 Tumors
    Cancer Genomics Proteomics, 15 (3), 193-200
    DOI 10.21873/cgp.20077, PubMed 29695401
  31. Simonsen TG, Lund KV, Hompland T, Kristensen GB, Rofstad EK (2018)
    DCE-MRI-Derived Measures of Tumor Hypoxia and Interstitial Fluid Pressure Predict Outcomes in Cervical Carcinoma
    Int J Radiat Oncol Biol Phys, 102 (4), 1193-1201
    DOI 10.1016/j.ijrobp.2018.04.035, PubMed 29859790
  32. Smogeli E, Cvancarova M, Wang Y, Davidson B, Kristensen G, Lindemann K (2018)
    Clinical Outcome of Patients With High-Risk Endometrial Carcinoma After Treatment With Chemotherapy Only
    Int J Gynecol Cancer, 28 (9), 1789-1795
    DOI 10.1097/IGC.0000000000001356, PubMed 30365455
  33. Vaccaro CA, López-Kostner F, Adriana DV, Palmero EI, Rossi BM, Antelo M, Solano A, Carraro DM, Forones NM, Bohorquez M, Lino-Silva LS, Buleje J, Spirandelli F, Abe-Sandes K, Nascimento I, Sullcahuaman Y, Sarroca C, Gonzalez ML, Herrando AI, Alvarez K, Neffa F, Galvão HC, Esperon P, Golubicki M, Cisterna D et al. (2018)
    From colorectal cancer pattern to the characterization of individuals at risk: Picture for genetic research in Latin America
    Int J Cancer, 145 (2), 318-326
    DOI 10.1002/ijc.31920, PubMed 30303536
  34. Vergote I, Coens C, Nankivell M, Kristensen GB, Parmar MKB, Ehlen T, Jayson GC, Johnson N, Swart AM, Verheijen R, McCluggage WG, Perren T, Panici PB, Kenter G, Casado A, Mendiola C, Stuart G, Reed NS, Kehoe S, EORTC, MRC CHORUS study investigators (2018)
    Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials
    Lancet Oncol, 19 (12), 1680-1687
    DOI 10.1016/S1470-2045(18)30566-7, PubMed 30413383
  35. Winje IM, Sheng X, Hansson KA, Solbrå A, Tennøe S, Saatcioglu F, Bruusgaard JC, Gundersen K (2018)
    Cachexia does not induce loss of myonuclei or muscle fibres during xenografted prostate cancer in mice
    Acta Physiol (Oxf), 225 (3), e13204
    DOI 10.1111/apha.13204, PubMed 30325108
  36. Xu C, Wang Y, Tu Q, Zhang Z, Chen M, Mwangi J, Li Y, Jin Y, Zhao X, Lai R (2018)
    Targeting surface nucleolin induces autophagy-dependent cell death in pancreatic cancer via AMPK activation
    Oncogene, 38 (11), 1832-1844
    DOI 10.1038/s41388-018-0556-x, PubMed 30356139

Publications 2017

  1. Agostini A, Brunetti M, Davidson B, Tropé CG, Heim S, Panagopoulos I, Micci F (2017)
    Genomic imbalances are involved in miR-30c and let-7a deregulation in ovarian tumors: implications for HMGA2 expression
    Oncotarget, 8 (13), 21554-21560
    DOI 10.18632/oncotarget.15795, PubMed 28423547
  2. Andreassen BK, Myklebust TÅ, Haug ES (2017)
    Crude mortality and loss of life expectancy of patients diagnosed with urothelial carcinoma of the urinary bladder in Norway
    Scand J Urol, 51 (1), 38-43
    DOI 10.1080/21681805.2016.1271354, PubMed 28084860
  3. Bengtsson E, Danielsen H, Treanor D, Gurcan MN, MacAulay C, Molnár B (2017)
    Computer-aided diagnostics in digital pathology
    Cytometry A, 91 (6), 551-554
    DOI 10.1002/cyto.a.23151, PubMed 28640523
  4. Brunetti M, Agostini A, Davidson B, Tropé CG, Heim S, Panagopoulos I, Micci F (2017)
    Recurrent fusion transcripts in squamous cell carcinomas of the vulva
    Oncotarget, 8 (10), 16843-16850
    DOI 10.18632/oncotarget.15167, PubMed 28186972
  5. Brunetti M, Panagopoulos I, Gorunova L, Davidson B, Heim S, Micci F (2017)
    RNA-sequencing identifies novel GREB1-NCOA2 fusion gene in a uterine sarcoma with the chromosomal translocation t(2;8)(p25;q13)
    Genes Chromosomes Cancer, 57 (4), 176-181
    DOI 10.1002/gcc.22518, PubMed 29218853
  6. Braadland PR, Giskeødegård G, Sandsmark E, Bertilsson H, Euceda LR, Hansen AF, Guldvik IJ, Selnæs KM, Grytli HH, Katz B, Svindland A, Bathen TF, Eri LM, Nygård S, Berge V, Taskén KA, Tessem MB (2017)
    Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy
    Br J Cancer, 117 (11), 1656-1664
    DOI 10.1038/bjc.2017.346, PubMed 28972967
  7. Clancy T, Dannenfelser R, Troyanskaya O, Malmberg KJ, Hovig E, Kristensen V (2017)
    Bioinformatics Approaches to Profile the Tumor Microenvironment for Immunotherapeutic Discovery
    Curr Pharm Des, 23 (32), 4716-4725
    DOI 10.2174/1381612823666170710154936, PubMed 28699527
  8. Cyll K, Ersvær E, Vlatkovic L, Pradhan M, Kildal W, Avranden Kjær M, Kleppe A, Hveem TS, Carlsen B, Gill S, Löffeler S, Haug ES, Wæhre H, Sooriakumaran P, Danielsen HE (2017)
    Tumour heterogeneity poses a significant challenge to cancer biomarker research
    Br J Cancer, 117 (3), 367-375
    DOI 10.1038/bjc.2017.171, PubMed 28618431
  9. Davidson B, Hellesylt E, Holth A, Danielsen HE, Skeie-Jensen T, Katz B (2017)
    Neuron navigator-2 and cyclin D2 are new candidate prognostic markers in uterine sarcoma
    Virchows Arch, 471 (3), 355-362
    DOI 10.1007/s00428-017-2172-5, PubMed 28643014
  10. Davidson B, Micci F (2017)
    Molecular characteristics of uterine sarcomas
    Expert Rev Mol Diagn, 17 (5), 515-522
    DOI 10.1080/14737159.2017.1311790, PubMed 28335657
  11. de Vries EMG, Färkkilä M, Milkiewicz P, Hov JR, Eksteen B, Thorburn D, Chazouillères O, Pares A, Nygård S, Gilja OH, Wunsch E, Invernizzi P, Carbone M, Bernuzzi F, Boberg KM, Røsjø H, Rosenberg W, Beuers UH, Ponsioen CY, Karlsen TH, Vesterhus M (2017)
    Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study
    Liver Int, 37 (10), 1554-1561
    DOI 10.1111/liv.13402, PubMed 28267887
  12. Domanska D, Vodák D, Lund-Andersen C, Salvatore S, Hovig E, Sandve GK (2017)
    The rainfall plot: its motivation, characteristics and pitfalls
    BMC Bioinformatics, 18 (1), 264
    DOI 10.1186/s12859-017-1679-8, PubMed 28521741
  13. Helland Å, Brustugun OT, Nakken S, Halvorsen AR, Dønnem T, Bremnes R, Busund LT, Sun J, Lorenz S, Solberg SK, Jørgensen LH, Vodak D, Myklebost O, Hovig E, Meza-Zepeda LA (2017)
    High number of kinome-mutations in non-small cell lung cancer is associated with reduced immune response and poor relapse-free survival
    Int J Cancer, 141 (1), 184-190
    DOI 10.1002/ijc.30726, PubMed 28387924
  14. Jin Y, Nenseth HZ, Saatcioglu F (2017)
    Role of PLZF as a tumor suppressor in prostate cancer
    Oncotarget, 8 (41), 71317-71324
    DOI 10.18632/oncotarget.19813, PubMed 29050363
  15. Kanduri C, Domanska D, Hovig E, Sandve GK (2017)
    Genome build information is an essential part of genomic track files
    Genome Biol, 18 (1), 175
    DOI 10.1186/s13059-017-1312-1, PubMed 28911336
  16. Kildal W, Pradhan M, Cyll K, Jacobsen JE, Kristensen GB, Danielsen HE (2017)
    [Properties of cancer cell DNA affects the prognosis]
    Tidsskr Nor Laegeforen, 137 (19)
    DOI 10.4045/tidsskr.16.0966, PubMed 29043733
  17. Kildal W, Pradhan M, Cyll K, Jacobsen JE, Kristensen GB, Danielsen HE (2017)
    Characteristics of tumor cell DNA affect prognosis
    Tidsskr. Nor. Laegeforen., 137 (19), 1519-1523
  18. Leske H, Brandal P, Rushing EJ, Niehusmann P (2017)
    IDH-mutant giant cell glioblastoma: A neglected tumor variant?
    Clin Neuropathol, 36 (6), 293-295
    DOI 10.5414/NP301054, PubMed 29035191
  19. Lewis N, Soslow RA, Delair DF, Park KJ, Murali R, Hollmann TJ, Davidson B, Micci F, Panagopoulos I, Hoang LN, Arias-Stella JA, Oliva E, Young RH, Hensley ML, Leitao MM, Hameed M, Benayed R, Ladanyi M, Frosina D, Jungbluth AA, Antonescu CR, Chiang S (2017)
    ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity
    Mod Pathol, 31 (4), 674-684
    DOI 10.1038/modpathol.2017.162, PubMed 29192652
  20. Lindemann K, Gibbs E, Åvall-Lundqvist E, dePont Christensen R, Woie K, Kalling M, Auranen A, Grenman S, Hoegberg T, Rosenberg P, Skeie-Jensen T, Hjerpe E, Dørum A, Gebski V, Kristensen G (2017)
    Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist)
    Br J Cancer, 116 (4), 455-463
    DOI 10.1038/bjc.2016.435, PubMed 28118323
  21. López-García C, Sansregret L, Domingo E, McGranahan N, Hobor S, Birkbak NJ, Horswell S, Grönroos E, Favero F, Rowan AJ, Matthews N, Begum S, Phillimore B, Burrell R, Oukrif D, Spencer-Dene B, Kovac M, Stamp G, Stewart A, Danielsen H, Novelli M, Tomlinson I, Swanton C (2017)
    BCL9L Dysfunction Impairs Caspase-2 Expression Permitting Aneuploidy Tolerance in Colorectal Cancer
    Cancer Cell, 31 (1), 79-93
    DOI 10.1016/j.ccell.2016.11.001, PubMed 28073006
  22. Lund KV, Simonsen TG, Kristensen GB, Rofstad EK (2017)
    Pretreatment late-phase DCE-MRI predicts outcome in locally advanced cervix cancer
    Acta Oncol, 56 (5), 675-681
    DOI 10.1080/0284186X.2017.1294762, PubMed 28447564
  23. Meisal R, Rounge TB, Christiansen IK, Eieland AK, Worren MM, Molden TF, Kommedal Ø, Hovig E, Leegaard TM, Ambur OH (2017)
    HPV Genotyping of Modified General Primer-Amplicons Is More Analytically Sensitive and Specific by Sequencing than by Hybridization
    PLoS One, 12 (1), e0169074
    DOI 10.1371/journal.pone.0169074, PubMed 28045981
  24. Micci F, Brunetti M, Dal Cin P, Nucci MR, Gorunova L, Heim S, Panagopoulos I (2017)
    Fusion of the genes BRD8 and PHF1 in endometrial stromal sarcoma
    Genes Chromosomes Cancer, 56 (12), 841-845
    DOI 10.1002/gcc.22485, PubMed 28758277
  25. Møller P, Hovig E (2017)
    The BRCA2 variant c.68-7 T>A is associated with breast cancer
    Hered Cancer Clin Pract, 15, 20 (Retracted)
    DOI 10.1186/s13053-017-0080-y, PubMed 29158857
  26. Møller P, Seppälä TT, Bernstein I, Holinski-Feder E, Sala P, Gareth Evans D, Lindblom A, Macrae F, Blanco I, Sijmons RH, Jeffries J, Vasen HFA, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen JT, Jenkins MA, Green K, Lalloo F, Sunde L, Mints M et al. (2017)
    Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database
    Gut, 67 (7), 1306-1316
    DOI 10.1136/gutjnl-2017-314057, PubMed 28754778
  27. Namløs HM, Zaikova O, Bjerkehagen B, Vodák D, Hovig E, Myklebost O, Boye K, Meza-Zepeda LA (2017)
    Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report
    BMC Cancer, 17 (1), 29
    DOI 10.1186/s12885-016-2992-8, PubMed 28061772
  28. Nygaard V, Rødland EA, Hovig E (2017)
    Reply to Towfic and others' letter to the editor
    Biostatistics, 18 (3), 586-587
    DOI 10.1093/biostatistics/kxx001, PubMed 28334081
  29. Ooi J, Wilson P, Walker G, Blaker P, DeMartino S, O'Donohue J, Reffitt D, Lanaspre E, Chang F, Meenan J, Dunn JM (2017)
    Dedicated Barrett's surveillance sessions managed by trained endoscopists improve dysplasia detection rate
    Endoscopy, 49 (6), 524-528
    DOI 10.1055/s-0043-103410, PubMed 28399610
  30. Panagopoulos I, Gorunova L, Bjerkehagen B, Andersen K, Lund-Iversen M, Heim S (2017)
    Loss of chromosome 13 material in cellular angiofibromas indicates pathogenetic similarity with spindle cell lipomas
    Diagn Pathol, 12 (1), 17
    DOI 10.1186/s13000-017-0607-6, PubMed 28193293
  31. Panagopoulos I, Gorunova L, Brunetti M, Agostini A, Andersen HK, Lobmaier I, Bjerkehagen B, Heim S (2017)
    Genetic heterogeneity in leiomyomas of deep soft tissue
    Oncotarget, 8 (30), 48769-48781
    DOI 10.18632/oncotarget.17953, PubMed 28591699
  32. Panagopoulos I, Gorunova L, Lobmaier I, Andersen HK, Bjerkehagen B, Heim S (2017)
    Cytogenetic Analysis of a Pseudoangiomatous Pleomorphic/Spindle Cell Lipoma
    Anticancer Res, 37 (5), 2219-2223
    DOI 10.21873/anticanres.11557, PubMed 28476785
  33. Panagopoulos I, Gorunova L, Lobmaier I, Bjerkehagen B, Heim S (2017)
    Karyotyping and analysis of GNAS locus in intramuscular myxomas
    Oncotarget, 8 (13), 22086-22094
    DOI 10.18632/oncotarget.14986, PubMed 28160572
  34. Panagopoulos I, Gorunova L, Lobmaier I, Bjerkehagen B, Heim S (2017)
    Identification of SETD2-NF1 fusion gene in a pediatric spindle cell tumor with the chromosomal translocation t(3;17)(p21;q12)
    Oncol Rep, 37 (6), 3181-3188
    DOI 10.3892/or.2017.5628, PubMed 28498454
  35. Panagopoulos I, Gorunova L, Spetalen S, Bassarova A, Beiske K, Micci F, Heim S (2017)
    Fusion of the genes ataxin 2 like, ATXN2L, and Janus kinase 2, JAK2, in cutaneous CD4 positive T-cell lymphoma
    Oncotarget, 8 (61), 103775-103784
    DOI 10.18632/oncotarget.21790, PubMed 29262599
  36. Panagopoulos I, Gorunova L, Torkildsen S, Tierens A, Heim S, Micci F (2017)
    FAM53B truncation caused by t(10;19)(q26;q13) chromosome translocation in acute lymphoblastic leukemia
    Oncol Lett, 13 (4), 2216-2220
    DOI 10.3892/ol.2017.5705, PubMed 28454383
  37. Panagopoulos I, Gorunova L, Torkildsen S, Tjønnfjord GE, Micci F, Heim S (2017)
    DEK-NUP214-Fusion Identified by RNA-Sequencing of an Acute Myeloid Leukemia with t(9;12)(q34;q15)
    Cancer Genomics Proteomics, 14 (6), 437-443
    DOI 10.21873/cgp.20053, PubMed 29109093
  38. Proctor L, Pradhan M, Leung S, Cheng A, Lee CH, Soslow RA, Gilks CB, Talhouk A, McAlpine JM, Danielsen HE, Hoang LN (2017)
    Assessment of DNA Ploidy in the ProMisE molecular subgroups of endometrial cancer
    Gynecol Oncol, 146 (3), 596-602
    DOI 10.1016/j.ygyno.2017.06.020, PubMed 28647100
  39. Ray-Coquard I, Trama A, Seckl MJ, Fotopoulou C, Pautier P, Pignata S, Kristensen G, Mangili G, Falconer H, Massuger L, Sehouli J, Pujade-Lauraine E, Lorusso D, Amant F, Rokkones E, Vergote I, Ledermann JA, RARECARENet Working Group (2017)
    Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting
    Eur J Surg Oncol, 45 (1), 67-74
    DOI 10.1016/j.ejso.2017.09.025, PubMed 29108961
  40. Ree AH, Russnes HG, Heinrich D, Dueland S, Boye K, Nygaard V, Silwal-Pandit L, Østrup O, Hovig E, Nygaard V, Rødland EA, Nakken S, Øien JT, Johansen C, Bergheim IR, Skarpeteig V, Sathermugathevan M, Sauer T, Lund-Iversen M, Beiske K, Nasser S, Julsrud L, Reisse CH, Ruud EA, Flørenes VA et al. (2017)
    Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
    ESMO Open, 2 (2), e000158
    DOI 10.1136/esmoopen-2017-000158, PubMed 28761742
  41. Romaine A, Sørensen IW, Zeltz C, Lu N, Erusappan PM, Melleby AO, Zhang L, Bendiksen B, Robinson EL, Aronsen JM, Herum KM, Danielsen HE, Sjaastad I, Christensen G, Gullberg D (2017)
    Overexpression of integrin α11 induces cardiac fibrosis in mice
    Acta Physiol (Oxf), 222 (2)
    DOI 10.1111/apha.12932, PubMed 28771943
  42. Rossi BM, Palmero EI, López-Kostner F, Sarroca C, Vaccaro CA, Spirandelli F, Ashton-Prolla P, Rodriguez Y, de Campos Reis Galvão H, Reis RM, Escremim de Paula A, Capochin Romagnolo LG, Alvarez K, Della Valle A, Neffa F, Kalfayan PG, Spirandelli E, Chialina S, Gutiérrez Angulo M, Castro-Mujica MDC, Sanchez de Monte J, Quispe R, da Silva SD, Rossi NT, Barletta-Carrillo C et al. (2017)
    A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin America
    BMC Cancer, 17 (1), 623
    DOI 10.1186/s12885-017-3599-4, PubMed 28874130
  43. Røe ÅT, Aronsen JM, Skårdal K, Hamdani N, Linke WA, Danielsen HE, Sejersted OM, Sjaastad I, Louch WE (2017)
    Increased passive stiffness promotes diastolic dysfunction despite improved Ca2+ handling during left ventricular concentric hypertrophy
    Cardiovasc Res, 113 (10), 1161-1172
    DOI 10.1093/cvr/cvx087, PubMed 28472418
  44. Seppälä T, Pylvänäinen K, Evans DG, Järvinen H, Renkonen-Sinisalo L, Bernstein I, Holinski-Feder E, Sala P, Lindblom A, Macrae F, Blanco I, Sijmons R, Jeffries J, Vasen H, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen J, Jenkins M, Genuardi M, Green K et al. (2017)
    Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report
    Hered Cancer Clin Pract, 15, 18
    DOI 10.1186/s13053-017-0078-5, PubMed 29046738
  45. Simovski B, Vodák D, Gundersen S, Domanska D, Azab A, Holden L, Holden M, Grytten I, Rand K, Drabløs F, Johansen M, Mora A, Lund-Andersen C, Fromm B, Eskeland R, Gabrielsen OS, Ferkingstad E, Nakken S, Bengtsen M, Nederbragt AJ, Thorarensen HS, Akse JA, Glad I, Hovig E, Sandve GK (2017)
    GSuite HyperBrowser: integrative analysis of dataset collections across the genome and epigenome
    Gigascience, 6 (7), 1-12
    DOI 10.1093/gigascience/gix032, PubMed 28459977
  46. Smebye ML, Agostini A, Johannessen B, Thorsen J, Davidson B, Tropé CG, Heim S, Skotheim RI, Micci F (2017)
    Involvement of DPP9 in gene fusions in serous ovarian carcinoma
    BMC Cancer, 17 (1), 642
    DOI 10.1186/s12885-017-3625-6, PubMed 28893231
  47. Torkildsen S, Brunetti M, Gorunova L, Spetalen S, Beiske K, Heim S, Panagopoulos I (2017)
    Rearrangement of the Chromatin Organizer Special AT-rich Binding Protein 1 Gene, SATB1, Resulting from a t(3;5)(p24;q14) Chromosomal Translocation in Acute Myeloid Leukemia
    Anticancer Res, 37 (2), 693-698
    DOI 10.21873/anticanres.11365, PubMed 28179318
  48. Urbanucci A, Barfeld SJ, Kytölä V, Itkonen HM, Coleman IM, Vodák D, Sjöblom L, Sheng X, Tolonen T, Minner S, Burdelski C, Kivinummi KK, Kohvakka A, Kregel S, Takhar M, Alshalalfa M, Davicioni E, Erho N, Lloyd P, Karnes RJ, Ross AE, Schaeffer EM, Vander Griend DJ, Knapp S, Corey E et al. (2017)
    Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer
    Cell Rep, 19 (10), 2045-2059
    DOI 10.1016/j.celrep.2017.05.049, PubMed 28591577
  49. Vesterhus M, Holm A, Hov JR, Nygård S, Schrumpf E, Melum E, Thorbjørnsen LW, Paulsen V, Lundin K, Dale I, Gilja OH, Zweers SJLB, Vatn M, Schaap FG, Jansen PLM, Ueland T, Røsjø H, Moum B, Ponsioen CY, Boberg KM, Färkkilä M, Karlsen TH, Lund-Johansen F (2017)
    Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis
    J Hepatol, 66 (6), 1214-1222
    DOI 10.1016/j.jhep.2017.01.019, PubMed 28161472
  50. Vistad I, Bjørge L, Solheim O, Fiane B, Sachse K, Tjugum J, Skrøppa S, Bentzen AG, Stokstad T, Iversen GA, Salvesen HB, Kristensen GB, Dørum A (2017)
    A national, prospective observational study of first recurrence after primary treatment for gynecological cancer in Norway
    Acta Obstet Gynecol Scand, 96 (10), 1162-1169
    DOI 10.1111/aogs.13199, PubMed 28795770
  51. Winther JA, Brynildsen J, Høiseth AD, Strand H, Følling I, Christensen G, Nygård S, Røsjø H, Omland T (2017)
    Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 study
    Respir Res, 18 (1), 184
    DOI 10.1186/s12931-017-0665-z, PubMed 29100503
  52. Zeki SS, Ooi J, Wilson P, Walker G, Blaker P, DeMartino S, O'Donohue J, Reffitt D, Lanaspre E, Chang F, Meenan J, Dunn JM (2017)
    Reply to Westerveld et al. and Schembri et al
    Endoscopy, 49 (11), 1115
    DOI 10.1055/s-0043-118217, PubMed 29073698

Publications 2016

  1. Agostini A, Brunetti M, Davidson B, Trope CG, Heim S, Panagopoulos I, Micci F (2016)
    Expressions of miR-30c and let-7a are inversely correlated with HMGA2 expression in squamous cell carcinoma of the vulva
    Oncotarget, 7 (51), 85058-85062
    DOI 10.18632/oncotarget.13187, PubMed 27835588
  2. Agostini A, Gorunova L, Bjerkehagen B, Lobmaier I, Heim S, Panagopoulos I (2016)
    Molecular characterization of the t(4;12)(q27~28;q14~15) chromosomal rearrangement in lipoma
    Oncol Lett, 12 (3), 1701-1704
    DOI 10.3892/ol.2016.4834, PubMed 27588119
  3. Agostini A, Panagopoulos I, Davidson B, Trope CG, Heim S, Micci F (2016)
    A novel truncated form of HMGA2 in tumors of the ovaries
    Oncol Lett, 12 (2), 1559-1563
    DOI 10.3892/ol.2016.4805, PubMed 27446471
  4. Alver TN, Lavelle TJ, Longva AS, Øy GF, Hovig E, Bøe SL (2016)
    MITF depletion elevates expression levels of ERBB3 receptor and its cognate ligand NRG1-beta in melanoma
    Oncotarget, 7 (34), 55128-55140
    DOI 10.18632/oncotarget.10422, PubMed 27391157
  5. Andreassen R, Rangnes F, Sivertsen M, Chiang M, Tran M, Worren MM (2016)
    Discovery of miRNAs and Their Corresponding miRNA Genes in Atlantic Cod (Gadus morhua): Use of Stable miRNAs as Reference Genes Reveals Subgroups of miRNAs That Are Highly Expressed in Particular Organs
    PLoS One, 11 (4), e0153324
    DOI 10.1371/journal.pone.0153324, PubMed 27128807
  6. Behnan J, Stangeland B, Hosainey SA, Joel M, Olsen TK, Micci F, Glover JC, Isakson P, Brinchmann JE (2016)
    Differential propagation of stroma and cancer stem cells dictates tumorigenesis and multipotency
    Oncogene, 36 (4), 570-584
    DOI 10.1038/onc.2016.230, PubMed 27345406
  7. Björklund AT, Clancy T, Goodridge JP, Béziat V, Schaffer M, Hovig E, Ljunggren HG, Ljungman PT, Malmberg KJ (2016)
    Naive Donor NK Cell Repertoires Associated with Less Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
    J Immunol, 196 (3), 1400-11
    DOI 10.4049/jimmunol.1501434, PubMed 26746188
  8. Clancy T, Hovig E (2016)
    Profiling networks of distinct immune-cells in tumors
    BMC Bioinformatics, 17 (1), 263
    DOI 10.1186/s12859-016-1141-3, PubMed 27377892
  9. Davidson B, Kjæreng ML, Førsund M, Danielsen HE, Kristensen GB, Abeler VM (2016)
    Progesterone Receptor Expression Is an Independent Prognosticator in FIGO Stage I Uterine Leiomyosarcoma
    Am J Clin Pathol, 145 (4), 449-58
    DOI 10.1093/ajcp/aqw030, PubMed 27149024
  10. Ferrante L, Rognum TO, Vege Å, Nygård S, Opdal SH (2016)
    Altered gene expression and possible immunodeficiency in cases of sudden infant death syndrome
    Pediatr Res, 80 (1), 77-84
    DOI 10.1038/pr.2016.45, PubMed 26959483
  11. Fjeldbo CS, Julin CH, Lando M, Forsberg MF, Aarnes EK, Alsner J, Kristensen GB, Malinen E, Lyng H (2016)
    Integrative Analysis of DCE-MRI and Gene Expression Profiles in Construction of a Gene Classifier for Assessment of Hypoxia-Related Risk of Chemoradiotherapy Failure in Cervical Cancer
    Clin Cancer Res, 22 (16), 4067-76
    DOI 10.1158/1078-0432.CCR-15-2322, PubMed 27012812
  12. Fjeldbo CS, Aarnes EK, Malinen E, Kristensen GB, Lyng H (2016)
    Identification and Validation of Reference Genes for RT-qPCR Studies of Hypoxia in Squamous Cervical Cancer Patients
    PLoS One, 11 (5), e0156259
    DOI 10.1371/journal.pone.0156259, PubMed 27244197
  13. Halvorsen AR, Silwal-Pandit L, Meza-Zepeda LA, Vodak D, Vu P, Sagerup C, Hovig E, Myklebost O, Børresen-Dale AL, Brustugun OT, Helland Å (2016)
    TP53 Mutation Spectrum in Smokers and Never Smoking Lung Cancer Patients
    Front Genet, 7, 85
    DOI 10.3389/fgene.2016.00085, PubMed 27242894
  14. Haugvik SP, Vodák D, Haugom L, Hovig E, Gladhaug IP, Heim S, Micci F (2016)
    Transcriptomic Profiling of Tumor Aggressiveness in Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms
    Pancreas, 45 (8), 1196-203
    DOI 10.1097/MPA.0000000000000610, PubMed 26918873
  15. Holmen S, Galappaththi-Arachchige HN, Kleppa E, Pillay P, Naicker T, Taylor M, Onsrud M, Kjetland EF, Albregtsen F (2016)
    Characteristics of Blood Vessels in Female Genital Schistosomiasis: Paving the Way for Objective Diagnostics at the Point of Care
    PLoS Negl Trop Dis, 10 (4), e0004628
    DOI 10.1371/journal.pntd.0004628, PubMed 27073857
  16. Hveem TS, Kleppe A, Vlatkovic L, Ersvær E, Wæhre H, Nielsen B, Kjær MA, Pradhan M, Syvertsen RA, Nesheim JA, Liestøl K, Albregtsen F, Danielsen HE (2016)
    Chromatin changes predict recurrence after radical prostatectomy
    Br J Cancer, 114 (11), 1243-50
    DOI 10.1038/bjc.2016.96, PubMed 27124335
  17. Hveem TS, Njølstad TS, Nielsen B, Syvertsen RA, Nesheim JA, Kjæreng ML, Kildal W, Pradhan M, Marcickiewicz J, Tingulstad S, Staff AC, Haugland HK, Eraker R, Oddenes K, Rokne JA, Tjugum J, Lode MS, Amant F, Werner HM, Bjørge L, Albregtsen F, Liestøl K, Salvesen HB, Trovik J, Danielsen HE et al. (2016)
    Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial Cancer
    Cancer Epidemiol Biomarkers Prev, 26 (1), 61-67
    DOI 10.1158/1055-9965.EPI-16-0215, PubMed 27587790
  18. Haakensen VD, Nygaard V, Greger L, Aure MR, Fromm B, Bukholm IR, Lüders T, Chin SF, Git A, Caldas C, Kristensen VN, Brazma A, Børresen-Dale AL, Hovig E, Helland Å (2016)
    Subtype-specific micro-RNA expression signatures in breast cancer progression
    Int J Cancer, 139 (5), 1117-28
    DOI 10.1002/ijc.30142, PubMed 27082076
  19. Johannessen LE, Panagopoulos I, Haugvik SP, Gladhaug IP, Heim S, Micci F (2016)
    Upregulation of INS-IGF2 read-through expression and identification of a novel INS-IGF2 splice variant in insulinomas
    Oncol Rep, 36 (5), 2653-2662
    DOI 10.3892/or.2016.5132, PubMed 27667266
  20. Kummen M, Holm K, Anmarkrud JA, Nygård S, Vesterhus M, Høivik ML, Trøseid M, Marschall HU, Schrumpf E, Moum B, Røsjø H, Aukrust P, Karlsen TH, Hov JR (2016)
    The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls
    Gut, 66 (4), 611-619
    DOI 10.1136/gutjnl-2015-310500, PubMed 26887816
  21. Lindemann K, Kristensen G, Mirza MR, Davies L, Hilpert F, Romero I, Ayhan A, Burges A, Rubio MJ, Raspagliesi F, Huizing M, Creemers GJ, Lykka M, Lee CK, Gebski V, Pujade-Lauraine E (2016)
    Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial
    Ann Oncol, 27 (8), 1505-10
    DOI 10.1093/annonc/mdw238, PubMed 27407100
  22. Lyngbakken MN, Røsjø H, Holmen OL, Nygård S, Dalen H, Hveem K, Omland T (2016)
    Gender, High-Sensitivity Troponin I, and the Risk of Cardiovascular Events (from the Nord-Trøndelag Health Study)
    Am J Cardiol, 118 (6), 816-821
    DOI 10.1016/j.amjcard.2016.06.043, PubMed 27453509
  23. Lyngbakken MN, Skranes JB, de Lemos JA, Nygård S, Dalen H, Hveem K, Røsjø H, Omland T (2016)
    Impact of Smoking on Circulating Cardiac Troponin I Concentrations and Cardiovascular Events in the General Population: The HUNT Study (Nord-Trøndelag Health Study)
    Circulation, 134 (24), 1962-1972
    DOI 10.1161/CIRCULATIONAHA.116.023726, PubMed 27815376
  24. Micci F, Gorunova L, Agostini A, Johannessen LE, Brunetti M, Davidson B, Heim S, Panagopoulos I (2016)
    Cytogenetic and molecular profile of endometrial stromal sarcoma
    Genes Chromosomes Cancer, 55 (11), 834-46
    DOI 10.1002/gcc.22380, PubMed 27219024
  25. Munkley J, Vodak D, Livermore KE, James K, Wilson BT, Knight B, Mccullagh P, Mcgrath J, Crundwell M, Harries LW, Leung HY, Robson CN, Mills IG, Rajan P, Elliott DJ (2016)
    Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell Viability
    EBioMedicine, 8, 103-116
    DOI 10.1016/j.ebiom.2016.04.018, PubMed 27428423
  26. Møller P, Seppälä T, Bernstein I, Holinski-Feder E, Sala P, Evans DG, Lindblom A, Macrae F, Blanco I, Sijmons R, Jeffries J, Vasen H, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen J, Jenkins M, Green K, Lalloo F, Sunde L, Mints M et al. (2016)
    Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database
    Gut, 66 (9), 1657-1664
    DOI 10.1136/gutjnl-2016-311403, PubMed 27261338
  27. Olsen TK, Panagopoulos I, Gorunova L, Micci F, Andersen K, Kilen Andersen H, Meling TR, Due-Tønnessen B, Scheie D, Heim S, Brandal P (2016)
    Novel fusion genes and chimeric transcripts in ependymal tumors
    Genes Chromosomes Cancer, 55 (12), 944-953
    DOI 10.1002/gcc.22392, PubMed 27401149
  28. Panagopoulos I, Gorunova L, Agostini A, Lobmaier I, Bjerkehagen B, Heim S (2016)
    Fusion of the HMGA2 and C9orf92 genes in myolipoma with t(9;12)(p22;q14)
    Diagn Pathol, 11, 22
    DOI 10.1186/s13000-016-0472-8, PubMed 26857357
  29. Panagopoulos I, Gorunova L, Kerndrup G, Spetalen S, Tierens A, Osnes LT, Andersen K, Müller LS, Hellebostad M, Zeller B, Heim S (2016)
    Rare MLL-ELL fusion transcripts in childhood acute myeloid leukemia-association with young age and myeloid sarcomas?
    Exp Hematol Oncol, 5, 8
    DOI 10.1186/s40164-016-0037-2, PubMed 26949571
  30. Panagopoulos I, Gorunova L, Lund-Iversen M, Lobmaier I, Bjerkehagen B, Heim S (2016)
    Recurrent fusion of the genes FN1 and ALK in gastrointestinal leiomyomas
    Mod Pathol, 29 (11), 1415-1423
    DOI 10.1038/modpathol.2016.129, PubMed 27469327
  31. Panagopoulos I, Gorunova L, Viset T, Heim S (2016)
    Gene fusions AHRR-NCOA2, NCOA2-ETV4, ETV4-AHRR, P4HA2-TBCK, and TBCK-P4HA2 resulting from the translocations t(5;8;17)(p15;q13;q21) and t(4;5)(q24;q31) in a soft tissue angiofibroma
    Oncol Rep, 36 (5), 2455-2462
    DOI 10.3892/or.2016.5096, PubMed 27633981
  32. Panagopoulos I, Torkildsen S, Gorunova L, Ulvmoen A, Tierens A, Zeller B, Heim S (2016)
    RUNX1 truncation resulting from a cryptic and novel t(6;21)(q25;q22) chromosome translocation in acute myeloid leukemia: A case report
    Oncol Rep, 36 (5), 2481-2488
    DOI 10.3892/or.2016.5119, PubMed 27667292
  33. Ruhlmann CH, Christensen TB, Dohn LH, Paludan M, Rønnengart E, Halekoh U, Hilpert F, Feyer P, Kristensen G, Hansen O, Keefe D, Herrstedt J (2016)
    Efficacy and safety of fosaprepitant for the prevention of nausea and emesis during 5 weeks of chemoradiotherapy for cervical cancer (the GAND-emesis study): a multinational, randomised, placebo-controlled, double-blind, phase 3 trial
    Lancet Oncol, 17 (4), 509-518
    DOI 10.1016/S1470-2045(15)00615-4, PubMed 26952945
  34. Sikkeland J, Sheng X, Jin Y, Saatcioglu F (2016)
    STAMPing at the crossroads of normal physiology and disease states
    Mol Cell Endocrinol, 425, 26-36
    DOI 10.1016/j.mce.2016.02.013, PubMed 26911931
  35. Silva MP, Barros-Silva JD, Ersvær E, Kildal W, Hveem TS, Pradhan M, Vieira J, Teixeira MR, Danielsen HE (2016)
    Cancer Prognosis Defined by the Combined Analysis of 8q, PTEN and ERG
    Transl Oncol, 9 (6), 575-582
    DOI 10.1016/j.tranon.2016.08.005, PubMed 27916292
  36. Smebye ML, Haugom L, Davidson B, Trope CG, Heim S, Skotheim RI, Micci F (2016)
    Bilateral ovarian carcinomas differ in the expression of metastasis-related genes
    Oncol Lett, 13 (1), 184-190
    DOI 10.3892/ol.2016.5384, PubMed 28123539
  37. Smogeli E, Davidson B, Cvancarova M, Holth A, Katz B, Risberg B, Kristensen G, Lindemann K (2016)
    L1CAM as a prognostic marker in stage I endometrial cancer: a validation study
    BMC Cancer, 16, 596
    DOI 10.1186/s12885-016-2631-4, PubMed 27488577
  38. Sorio R, Roemer-Becuwe C, Hilpert F, Gibbs E, García Y, Kaern J, Huizing M, Witteveen P, Zagouri F, Coeffic D, Lück HJ, González-Martín A, Kristensen G, Levaché CB, Lee CK, Gebski V, Pujade-Lauraine E, AURELIA Investigators (2016)
    Safety and efficacy of single-agent bevacizumab-containing therapy in elderly patients with platinum-resistant recurrent ovarian cancer: Subgroup analysis of the randomised phase III AURELIA trial
    Gynecol Oncol, 144 (1), 65-71
    DOI 10.1016/j.ygyno.2016.11.006, PubMed 27871723
  39. Späth F, Andersson U, Dahlin AM, Langseth H, Hovig E, Johannesen TB, Grankvist K, Björkblom B, Wibom C, Melin B (2016)
    Pre-diagnostic serum levels of EGFR and ErbB2 and genetic glioma risk variants: a nested case-control study
    Tumour Biol, 37 (8), 11065-72
    DOI 10.1007/s13277-015-4742-y, PubMed 26906551
  40. Storm M, Sheng X, Arnoldussen YJ, Saatcioglu F (2016)
    Prostate cancer and the unfolded protein response
    Oncotarget, 7 (33), 54051-54066
    DOI 10.18632/oncotarget.9912, PubMed 27303918
  41. Tesikova M, Dezitter X, Nenseth HZ, Klokk TI, Mueller F, Hager GL, Saatcioglu F (2016)
    Divergent Binding and Transactivation by Two Related Steroid Receptors at the Same Response Element
    J Biol Chem, 291 (22), 11899-910
    DOI 10.1074/jbc.M115.684480, PubMed 27056330
  42. Trillsch F, Mahner S, Hilpert F, Davies L, García-Martínez E, Kristensen G, Savarese A, Vuylsteke P, Los M, Zagouri F, Gladieff L, Sehouli J, Khoon Lee C, Gebski V, Pujade-Lauraine E (2016)
    Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial
    Ann Oncol, 27 (9), 1733-9
    DOI 10.1093/annonc/mdw236, PubMed 27287207
  43. Tunsjø HS, Kalyanasundaram S, Worren MM, Leegaard TM, Moen AEF (2016)
    High frequency of occupied attB regions in Norwegian Staphylococcus aureus isolates supports a two-step MRSA screening algorithm
    Eur J Clin Microbiol Infect Dis, 36 (1), 65-74
    DOI 10.1007/s10096-016-2771-0, PubMed 27638009
  44. Vandraas K, Tjønnfjord GE, Johannesen TB, Brandal P (2016)
    Persistent bone marrow depression following short-term treatment with temozolomide
    BMJ Case Rep, 2016
    DOI 10.1136/bcr-2016-215797, PubMed 27130558
  45. Våtsveen TK, Børset M, Dikic A, Tian E, Micci F, Lid AH, Meza-Zepeda LA, Coward E, Waage A, Sundan A, Kuehl WM, Holien T (2016)
    VOLIN and KJON-Two novel hyperdiploid myeloma cell lines
    Genes Chromosomes Cancer, 55 (11), 890-901
    DOI 10.1002/gcc.22388, PubMed 27311012

Publications 2015

  1. Agostini A, Panagopoulos I, Andersen HK, Johannesen LE, Davidson B, Tropé CG, Heim S, Micci F (2015)
    HMGA2 expression pattern and TERT mutations in tumors of the vulva
    Oncol Rep, 33 (6), 2675-80
    DOI 10.3892/or.2015.3882, PubMed 25823555
  2. Alioto TS, Buchhalter I, Derdak S, Hutter B, Eldridge MD, Hovig E, Heisler LE, Beck TA, Simpson JT, Tonon L, Sertier AS, Patch AM, Jäger N, Ginsbach P, Drews R, Paramasivam N, Kabbe R, Chotewutmontri S, Diessl N, Previti C, Schmidt S, Brors B, Feuerbach L, Heinold M, Gröbner S et al. (2015)
    A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing
    Nat Commun, 6, 10001
    DOI 10.1038/ncomms10001, PubMed 26647970
  3. Andreassen OA, Desikan RS, Wang Y, Thompson WK, Schork AJ, Zuber V, Doncheva NT, Ellinghaus E, Albrecht M, Mattingsdal M, Franke A, Lie BA, Mills IG, Aukrust P, McEvoy LK, Djurovic S, Karlsen TH, Dale AM (2015)
    Correction: Abundant Genetic Overlap between Blood Lipids and Immune-Mediated Diseases Indicates Shared Molecular Genetic Mechanisms
    PLoS One, 10 (5), e0128048
    DOI 10.1371/journal.pone.0128048, PubMed 25978331
  4. Andreassen OA, Thompson WK, Schork AJ, Ripke S, Mattingsdal M, Kelsoe JR, Kendler KS, O'Donovan MC, Rujescu D, Werge T, Sklar P, Psychiatric Genomics Consortium (PGC), Bipolar Disorder and Schizophrenia Working Groups, Roddey JC, Chen CH, McEvoy L, Desikan RS, Djurovic S, Dale AM (2015)
    Correction: Improved Detection of Common Variants Associated with Schizophrenia and Bipolar Disorder Using Pleiotropy-Informed Conditional False Discovery Rate
    PLoS Genet, 11 (11), e1005544
    DOI 10.1371/journal.pgen.1005544, PubMed 26540268
  5. Bassarova A, Trøen G, Spetalen S, Micci F, Tierens A, Delabie J (2015)
    Lymphoplasmacytic lymphoma and marginal zone lymphoma in the bone marrow: paratrabecular involvement as an important distinguishing feature
    Am J Clin Pathol, 143 (6), 797-806
    DOI 10.1309/AJCP6ZODWV1CIDME, PubMed 25972321
  6. Bengtsen M, Klepper K, Gundersen S, Cuervo I, Drabløs F, Hovig E, Sandve GK, Gabrielsen OS, Eskeland R (2015)
    c-Myb Binding Sites in Haematopoietic Chromatin Landscapes
    PLoS One, 10 (7), e0133280
    DOI 10.1371/journal.pone.0133280, PubMed 26208222
  7. Blaker YN, Brodtkorb M, Maddison J, Hveem TS, Nesheim JA, Mohn HM, Kolstad A, Geisler CH, Liestøl K, Smeland EB, Holte H, Delabie J, Danielsen H (2015)
    Computerized image analysis of the Ki-67 proliferation index in mantle cell lymphoma
    Histopathology, 67 (1), 62-9
    DOI 10.1111/his.12624, PubMed 25431344
  8. Christiansen IK, Sandve GK, Schmitz M, Dürst M, Hovig E (2015)
    Transcriptionally active regions are the preferred targets for chromosomal HPV integration in cervical carcinogenesis
    PLoS One, 10 (3), e0119566
    DOI 10.1371/journal.pone.0119566, PubMed 25793388
  9. Dale Rein I, Solberg Landsverk K, Micci F, Patzke S, Stokke T (2015)
    Replication-induced DNA damage after PARP inhibition causes G2 delay, and cell line-dependent apoptosis, necrosis and multinucleation
    Cell Cycle, 14 (20), 3248-60
    DOI 10.1080/15384101.2015.1085137, PubMed 26312527
  10. Danielsen HE, Pradhan M, Novelli M (2015)
    Revisiting tumour aneuploidy - the place of ploidy assessment in the molecular era
    Nat Rev Clin Oncol, 13 (5), 291-304
    DOI 10.1038/nrclinonc.2015.208, PubMed 26598944
  11. du Bois A, Kristensen G, Ray-Coquard I, Reuss A, Pignata S, Colombo N, Denison U, Vergote I, Del Campo JM, Ottevanger P, Heubner M, Minarik T, Sevin E, de Gregorio N, Bidziński M, Pfisterer J, Malander S, Hilpert F, Mirza MR, Scambia G, Meier W, Nicoletto MO, Bjørge L, Lortholary A, Sailer MO et al. (2015)
    Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial
    Lancet Oncol, 17 (1), 78-89
    DOI 10.1016/S1470-2045(15)00366-6, PubMed 26590673
  12. Ekstrøm PO, Nakken S, Johansen M, Hovig E (2015)
    Automated amplicon design suitable for analysis of DNA variants by melting techniques
    BMC Res Notes, 8, 667
    DOI 10.1186/s13104-015-1624-8, PubMed 26559640
  13. Fromm B, Billipp T, Peck LE, Johansen M, Tarver JE, King BL, Newcomb JM, Sempere LF, Flatmark K, Hovig E, Peterson KJ (2015)
    A Uniform System for the Annotation of Vertebrate microRNA Genes and the Evolution of the Human microRNAome
    Annu Rev Genet, 49, 213-42
    DOI 10.1146/annurev-genet-120213-092023, PubMed 26473382
  14. Holmen SD, Kjetland EF, Taylor M, Kleppa E, Lillebø K, Gundersen SG, Onsrud M, Albregtsen F (2015)
    Colourimetric image analysis as a diagnostic tool in female genital schistosomiasis
    Med Eng Phys, 37 (3), 309-14
    DOI 10.1016/j.medengphy.2014.12.007, PubMed 25630808
  15. Jin Y, Wang L, Qu S, Sheng X, Kristian A, Mælandsmo GM, Pällmann N, Yuca E, Tekedereli I, Gorgulu K, Alpay N, Sood A, Lopez-Berestein G, Fazli L, Rennie P, Risberg B, Wæhre H, Danielsen HE, Ozpolat B, Saatcioglu F (2015)
    STAMP2 increases oxidative stress and is critical for prostate cancer
    EMBO Mol Med, 7 (3), 315-31
    DOI 10.15252/emmm.201404181, PubMed 25680860
  16. Kaarbø M, Storm ML, Qu S, Wæhre H, Risberg B, Danielsen HE, Saatcioglu F (2015)
    Correction: TCTP is an androgen-regulated gene implicated in prostate cancer
    PLoS One, 10 (5), e0128727
    DOI 10.1371/journal.pone.0128727, PubMed 25973603
  17. Landin MA, Nygård S, Shabestari MG, Babaie E, Reseland JE, Osmundsen H (2015)
    Mapping the global mRNA transcriptome during development of the murine first molar
    Front Genet, 6, 47
    DOI 10.3389/fgene.2015.00047, PubMed 25852735
  18. Lando M, Fjeldbo CS, Wilting SM, C Snoek B, Aarnes EK, Forsberg MF, Kristensen GB, Steenbergen RD, Lyng H (2015)
    Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer
    Epigenetics, 10 (10), 970-80
    DOI 10.1080/15592294.2015.1085140, PubMed 26291246
  19. Lau C, Nygård S, Fure H, Olstad OK, Holden M, Lappegård KT, Brekke OL, Espevik T, Hovig E, Mollnes TE (2015)
    CD14 and complement crosstalk and largely mediate the transcriptional response to Escherichia coli in human whole blood as revealed by DNA microarray
    PLoS One, 10 (2), e0117261
    DOI 10.1371/journal.pone.0117261, PubMed 25706641
  20. Lau C, Olstad OK, Holden M, Nygård S, Fure H, Lappegård KT, Brekke OL, Espevik T, Hovig E, Mollnes TE (2015)
    Gene expression profiling of Gram-negative bacteria-induced inflammation in human whole blood: The role of complement and CD14-mediated innate immune response
    Genom Data, 5, 176-83
    DOI 10.1016/j.gdata.2015.05.019, PubMed 26484252
  21. Lee SH, Byrne EM, Hultman CM, Kähler A, Vinkhuyzen AA, Ripke S, Andreassen OA, Frisell T, Gusev A, Hu X, Karlsson R, Mantzioris VX, McGrath JJ, Mehta D, Stahl EA, Zhao Q, Kendler KS, Sullivan PF, Price AL, O'Donovan M, Okada Y, Mowry BJ, Raychaudhuri S, Wray NR, Schizophrenia Working Group of the Psychiatric Genomics Consortium and Rheumatoid Arthritis Consortium International et al. (2015)
    New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis
    Int J Epidemiol, 44 (5), 1706-21
    DOI 10.1093/ije/dyv136, PubMed 26286434
  22. Lund KV, Simonsen TG, Hompland T, Kristensen GB, Rofstad EK (2015)
    Short-term pretreatment DCE-MRI in prediction of outcome in locally advanced cervical cancer
    Radiother Oncol, 115 (3), 379-85
    DOI 10.1016/j.radonc.2015.05.001, PubMed 25998804
  23. Munkley J, Oltean S, Vodák D, Wilson BT, Livermore KE, Zhou Y, Star E, Floros VI, Johannessen B, Knight B, McCullagh P, McGrath J, Crundwell M, Skotheim RI, Robson CN, Leung HY, Harries LW, Rajan P, Mills IG, Elliott DJ (2015)
    The androgen receptor controls expression of the cancer-associated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer
    Oncotarget, 6 (33), 34358-74
    DOI 10.18632/oncotarget.6024, PubMed 26452038
  24. Møller P, Seppälä T, Bernstein I, Holinski-Feder E, Sala P, Evans DG, Lindblom A, Macrae F, Blanco I, Sijmons R, Jeffries J, Vasen H, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen J, Green K, Lalloo F, Sunde L, Mints M, Bertario L et al. (2015)
    Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database
    Gut, 66 (3), 464-472
    DOI 10.1136/gutjnl-2015-309675, PubMed 26657901
  25. Njølstad TS, Trovik J, Hveem TS, Kjæreng ML, Kildal W, Pradhan M, Marcickiewicz J, Tingulstad S, Staff AC, Haugland HK, Eraker R, Oddenes K, Rokne JA, Tjugum J, Lode MS, ENITEC Network/MoMaTEC Study Group, Amant F, Werner HM, Salvesen HB, Danielsen HE (2015)
    DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer
    Br J Cancer, 112 (10), 1656-64
    DOI 10.1038/bjc.2015.123, PubMed 25897678
  26. Nygaard V, Rødland EA, Hovig E (2015)
    Methods that remove batch effects while retaining group differences may lead to exaggerated confidence in downstream analyses
    Biostatistics, 17 (1), 29-39
    DOI 10.1093/biostatistics/kxv027, PubMed 26272994
  27. Olsen TK, Panagopoulos I, Meling TR, Micci F, Gorunova L, Thorsen J, Due-Tønnessen B, Scheie D, Lund-Iversen M, Krossnes B, Saxhaug C, Heim S, Brandal P (2015)
    Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity?
    Neuro Oncol, 17 (10), 1365-73
    DOI 10.1093/neuonc/nov039, PubMed 25795305
  28. Omland T, de Lemos JA, Holmen OL, Dalen H, Benth JŠ, Nygård S, Hveem K, Røsjø H (2015)
    Impact of sex on the prognostic value of high-sensitivity cardiac troponin I in the general population: the HUNT study
    Clin Chem, 61 (4), 646-56
    DOI 10.1373/clinchem.2014.234369, PubMed 25695851
  29. Oza AM, Cook AD, Pfisterer J, Embleton A, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Park-Simon TW, Rustin G, Joly F, Mirza MR, Plante M, Quinn M, Poveda A, Jayson GC, Stark D, Swart AM, Farrelly L, Kaplan R, Parmar MK, Perren TJ, ICON7 trial investigators (2015)
    Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
    Lancet Oncol, 16 (8), 928-36
    DOI 10.1016/S1470-2045(15)00086-8, PubMed 26115797
  30. Panagopoulos I, Bjerkehagen B, Gorunova L, Taksdal I, Heim S (2015)
    Rearrangement of chromosome bands 12q14~15 causing HMGA2-SOX5 gene fusion and HMGA2 expression in extraskeletal osteochondroma
    Oncol Rep, 34 (2), 577-84
    DOI 10.3892/or.2015.4035, PubMed 26043835
  31. Panagopoulos I, Gorunova L, Bjerkehagen B, Heim S (2015)
    Fusion of the genes EWSR1 and PBX3 in retroperitoneal leiomyoma with t(9;22)(q33;q12)
    PLoS One, 10 (4), e0124288
    DOI 10.1371/journal.pone.0124288, PubMed 25875009
  32. Panagopoulos I, Gorunova L, Bjerkehagen B, Heim S (2015)
    Novel KAT6B-KANSL1 fusion gene identified by RNA sequencing in retroperitoneal leiomyoma with t(10;17)(q22;q21)
    PLoS One, 10 (1), e0117010
    DOI 10.1371/journal.pone.0117010, PubMed 25621995
  33. Panagopoulos I, Gorunova L, Bjerkehagen B, Lobmaier I, Heim S (2015)
    LAMTOR1-PRKCD and NUMA1-SFMBT1 fusion genes identified by RNA sequencing in aneurysmal benign fibrous histiocytoma with t(3;11)(p21;q13)
    Cancer Genet, 208 (11), 545-51
    DOI 10.1016/j.cancergen.2015.07.007, PubMed 26432191
  34. Panagopoulos I, Gorunova L, Bjerkehagen B, Lobmaier I, Heim S (2015)
    Fusion of the TBL1XR1 and HMGA1 genes in splenic hemangioma with t(3;6)(q26;p21)
    Int J Oncol, 48 (3), 1242-50
    DOI 10.3892/ijo.2015.3310, PubMed 26708416
  35. Panagopoulos I, Gorunova L, Bjerkehagen B, Lobmaier I, Heim S (2015)
    The recurrent chromosomal translocation t(12;18)(q14~15;q12~21) causes the fusion gene HMGA2-SETBP1 and HMGA2 expression in lipoma and osteochondrolipoma
    Int J Oncol, 47 (3), 884-90
    DOI 10.3892/ijo.2015.3099, PubMed 26202160
  36. Panagopoulos I, Gorunova L, Taksdal I, Bjerkehagen B, Heim S (2015)
    Recurrent 12q13-15 chromosomal aberrations, high frequency of isocitrate dehydrogenase 1 mutations, and absence of high mobility group AT-hook 2 expression in periosteal chondromas
    Oncol Lett, 10 (1), 163-167
    DOI 10.3892/ol.2015.3197, PubMed 26170993
  37. Ricanek P, Lunde LK, Frye SA, Støen M, Nygård S, Morth JP, Rydning A, Vatn MH, Amiry-Moghaddam M, Tønjum T (2015)
    Reduced expression of aquaporins in human intestinal mucosa in early stage inflammatory bowel disease
    Clin Exp Gastroenterol, 8, 49-67
    DOI 10.2147/CEG.S70119, PubMed 25624769
  38. Ruhlmann CH, Iversen TZ, Okera M, Muhic A, Kristensen G, Feyer P, Hansen O, Herrstedt J (2015)
    Multinational study exploring patients' perceptions of side-effects induced by chemo-radiotherapy
    Radiother Oncol, 117 (2), 333-7
    DOI 10.1016/j.radonc.2015.09.014, PubMed 26372344
  39. Rustad EH, Dai HY, Hov H, Coward E, Beisvag V, Myklebost O, Hovig E, Nakken S, Vodák D, Meza-Zepeda LA, Sandvik AK, Wader KF, Misund K, Sundan A, Aarset H, Waage A (2015)
    BRAF V600E mutation in early-stage multiple myeloma: good response to broad acting drugs and no relation to prognosis
    Blood Cancer J, 5, e299
    DOI 10.1038/bcj.2015.24, PubMed 25794135
  40. Rydbeck H, Sandve GK, Ferkingstad E, Simovski B, Rye M, Hovig E (2015)
    ClusTrack: feature extraction and similarity measures for clustering of genome-wide data sets
    PLoS One, 10 (4), e0123261
    DOI 10.1371/journal.pone.0123261, PubMed 25879845
  41. Sevilla LM, Latorre V, Carceller E, Boix J, Vodák D, Mills IG, Pérez P (2015)
    Glucocorticoid receptor and Klf4 co-regulate anti-inflammatory genes in keratinocytes
    Mol Cell Endocrinol, 412, 281-9
    DOI 10.1016/j.mce.2015.05.015, PubMed 26001834
  42. Sheng X, Arnoldussen YJ, Storm M, Tesikova M, Nenseth HZ, Zhao S, Fazli L, Rennie P, Risberg B, Wæhre H, Danielsen H, Mills IG, Jin Y, Hotamisligil G, Saatcioglu F (2015)
    Divergent androgen regulation of unfolded protein response pathways drives prostate cancer
    EMBO Mol Med, 7 (6), 788-801
    DOI 10.15252/emmm.201404509, PubMed 25864123
  43. Stangeland B, Mughal AA, Grieg Z, Sandberg CJ, Joel M, Nygård S, Meling T, Murrell W, Vik Mo EO, Langmoen IA (2015)
    Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells
    Oncotarget, 6 (28), 26192-215
    DOI 10.18632/oncotarget.4613, PubMed 26295306
  44. Torkildsen S, Gorunova L, Beiske K, Tjønnfjord GE, Heim S, Panagopoulos I (2015)
    Novel ZEB2-BCL11B Fusion Gene Identified by RNA-Sequencing in Acute Myeloid Leukemia with t(2;14)(q22;q32)
    PLoS One, 10 (7), e0132736
    DOI 10.1371/journal.pone.0132736, PubMed 26186352
  45. Vesterhus M, Hov JR, Holm A, Schrumpf E, Nygård S, Godang K, Andersen IM, Naess S, Thorburn D, Saffioti F, Vatn M, Gilja OH, Lund-Johansen F, Syversveen T, Brabrand K, Parés A, Ponsioen CY, Pinzani M, Färkkilä M, Moum B, Ueland T, Røsjø H, Rosenberg W, Boberg KM, Karlsen TH (2015)
    Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis
    Hepatology, 62 (1), 188-97
    DOI 10.1002/hep.27825, PubMed 25833813

Publications 2014

  1. Amant F, Floquet A, Friedlander M, Kristensen G, Mahner S, Nam EJ, Powell MA, Ray-Coquard I, Siddiqui N, Sykes P, Westermann AM, Seddon B (2014)
    Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma
    Int J Gynecol Cancer, 24 (9 Suppl 3), S67-72
    DOI 10.1097/IGC.0000000000000205, PubMed 25033257
  2. Chilamakuri CS, Lorenz S, Madoui MA, Vodák D, Sun J, Hovig E, Myklebost O, Meza-Zepeda LA (2014)
    Performance comparison of four exome capture systems for deep sequencing
    BMC Genomics, 15, 449
    DOI 10.1186/1471-2164-15-449, PubMed 24912484
  3. Clancy T, Hovig E (2014)
    From proteomes to complexomes in the era of systems biology
    Proteomics, 14 (1), 24-41
    DOI 10.1002/pmic.201300230, PubMed 24243660
  4. Clancy T, Hovig E (2014)
    Differential protein network analysis of the immune cell lineage
    Biomed Res Int, 2014, 363408
    DOI 10.1155/2014/363408, PubMed 25309909
  5. Friedlander ML, Covens A, Glasspool RM, Hilpert F, Kristensen G, Kwon S, Selle F, Small W, Witteveen E, Russell P (2014)
    Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract
    Int J Gynecol Cancer, 24 (9 Suppl 3), S78-82
    DOI 10.1097/IGC.0000000000000239, PubMed 25341585
  6. Haugvik SP, Gorunova L, Haugom L, Eibak AM, Gladhaug IP, Heim S, Micci F (2014)
    Loss of 11p11 is a frequent and early event in sporadic nonfunctioning pancreatic neuroendocrine neoplasms
    Oncol Rep, 32 (3), 906-12
    DOI 10.3892/or.2014.3328, PubMed 25018013
  7. Heim S (2014)
    Boveri at 100: Boveri, chromosomes and cancer
    J Pathol, 234 (2), 138-41
    DOI 10.1002/path.4406, PubMed 25043504
  8. Hillestad V, Espe EK, Cero F, Larsen KO, Sjaastad I, Nygård S, Skjønsberg OH, Christensen G (2014)
    IL-18 neutralization during alveolar hypoxia improves left ventricular diastolic function in mice
    Acta Physiol (Oxf), 213 (2), 492-504
    DOI 10.1111/apha.12376, PubMed 25182570
  9. Hompland T, Lund KV, Ellingsen C, Kristensen GB, Rofstad EK (2014)
    Peritumoral interstitial fluid flow velocity predicts survival in cervical carcinoma
    Radiother Oncol, 113 (1), 132-8
    DOI 10.1016/j.radonc.2014.09.011, PubMed 25443501
  10. Hveem TS, Merok MA, Pretorius ME, Novelli M, Bævre MS, Sjo OH, Clinch N, Liestøl K, Svindland A, Lothe RA, Nesbakken A, Danielsen HE (2014)
    Prognostic impact of genomic instability in colorectal cancer
    Br J Cancer, 110 (8), 2159-64
    DOI 10.1038/bjc.2014.133, PubMed 24642618
  11. Håkelien AM, Bryne JC, Harstad KG, Lorenz S, Paulsen J, Sun J, Mikkelsen TS, Myklebost O, Meza-Zepeda LA (2014)
    The regulatory landscape of osteogenic differentiation
    Stem Cells, 32 (10), 2780-93
    DOI 10.1002/stem.1759, PubMed 24898411
  12. Johnston EL, Patel KV, Dunn JM (2014)
    An unusual complication of a duodenal ulcer
    Clin Gastroenterol Hepatol, 13 (6), e55-6
    DOI 10.1016/j.cgh.2014.11.032, PubMed 25496813
  13. Kumar RP, Albregtsen F, Reimers M, Edwin B, Langø T, Elle OJ (2014)
    Three-Dimensional Blood Vessel Segmentation and Centerline Extraction based on Two-Dimensional Cross-Section Analysis
    Ann Biomed Eng, 43 (5), 1223-34
    DOI 10.1007/s10439-014-1184-4, PubMed 25398332
  14. Lindemann K, Malander S, Christensen RD, Mirza MR, Kristensen GB, Aavall-Lundqvist E, Vergote I, Rosenberg P, Boman K, Nordstrøm B (2014)
    Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)
    BMC Cancer, 14, 68
    DOI 10.1186/1471-2407-14-68, PubMed 24498853
  15. Lundin C, Forestier E, Klarskov Andersen M, Autio K, Barbany G, Cavelier L, Golovleva I, Heim S, Heinonen K, Hovland R, Johannsson JH, Kjeldsen E, Nordgren A, Palmqvist L, Johansson B, Nordic Society of Pediatric Hematology Oncology (NOPHO), Swedish Cytogenetic Leukemia Study Group (SCLSG), NOPHO Leukemia Cytogenetic Study Group (NLCSG) (2014)
    Clinical and genetic features of pediatric acute lymphoblastic leukemia in Down syndrome in the Nordic countries
    J Hematol Oncol, 7, 32
    DOI 10.1186/1756-8722-7-32, PubMed 24726034
  16. Micci F, Gorunova L, Gatius S, Matias-Guiu X, Davidson B, Heim S, Panagopoulos I (2014)
    MEAF6/PHF1 is a recurrent gene fusion in endometrial stromal sarcoma
    Cancer Lett, 347 (1), 75-8
    DOI 10.1016/j.canlet.2014.01.030, PubMed 24530230
  17. Micci F, Haugom L, Abeler VM, Davidson B, Tropé CG, Heim S (2014)
    Genomic profile of ovarian carcinomas
    BMC Cancer, 14, 315
    DOI 10.1186/1471-2407-14-315, PubMed 24886194
  18. Micci F, Panagopoulos I, Thorsen J, Davidson B, Tropé CG, Heim S (2014)
    Low frequency of ESRRA-C11orf20 fusion gene in ovarian carcinomas
    PLoS Biol, 12 (2), e1001784
    DOI 10.1371/journal.pbio.1001784, PubMed 24504521
  19. Nenseth HZ, Dezitter X, Tesikova M, Mueller F, Klokk TI, Hager GL, Saatcioglu F (2014)
    Distinctly different dynamics and kinetics of two steroid receptors at the same response elements in living cells
    PLoS One, 9 (8), e105204
    DOI 10.1371/journal.pone.0105204, PubMed 25133404
  20. Nielsen B, Hveem TS, Kildal W, Abeler VM, Kristensen GB, Albregtsen F, Danielsen HE (2014)
    Entropy-based adaptive nuclear texture features are independent prognostic markers in a total population of uterine sarcomas
    Cytometry A, 87 (4), 315-25
    DOI 10.1002/cyto.a.22601, PubMed 25483227
  21. Nygård S, Reitan T, Clancy T, Nygaard V, Bjørnstad J, Skrbic B, Tønnessen T, Christensen G, Hovig E (2014)
    Identifying pathogenic processes by integrating microarray data with prior knowledge
    BMC Bioinformatics, 15, 115
    DOI 10.1186/1471-2105-15-115, PubMed 24758699
  22. Olsen TK, Gorunova L, Meling TR, Micci F, Scheie D, Due-Tønnessen B, Heim S, Brandal P (2014)
    Genomic characterization of ependymomas reveals 6q loss as the most common aberration
    Oncol Rep, 32 (2), 483-90
    DOI 10.3892/or.2014.3271, PubMed 24939246
  23. Oppelt A, Haugsten EM, Zech T, Danielsen HE, Sveen A, Lobert VH, Skotheim RI, Wesche J (2014)
    PIKfyve, MTMR3 and their product PtdIns5P regulate cancer cell migration and invasion through activation of Rac1
    Biochem J, 461 (3), 383-90
    DOI 10.1042/BJ20140132, PubMed 24840251
  24. Panagopoulos I, Bjerkehagen B, Gorunova L, Berner JM, Boye K, Heim S (2014)
    Several fusion genes identified by whole transcriptome sequencing in a spindle cell sarcoma with rearrangements of chromosome arm 12q and MDM2 amplification
    Int J Oncol, 45 (5), 1829-36
    DOI 10.3892/ijo.2014.2605, PubMed 25176350
  25. Panagopoulos I, Brandal P, Gorunova L, Bjerkehagen B, Heim S (2014)
    Novel CSF1-S100A10 fusion gene and CSF1 transcript identified by RNA sequencing in tenosynovial giant cell tumors
    Int J Oncol, 44 (5), 1425-32
    DOI 10.3892/ijo.2014.2326, PubMed 24604026
  26. Panagopoulos I, Gorunova L, Bjerkehagen B, Boye K, Heim S (2014)
    Chromosome aberrations and HEY1-NCOA2 fusion gene in a mesenchymal chondrosarcoma
    Oncol Rep, 32 (1), 40-4
    DOI 10.3892/or.2014.3180, PubMed 24839999
  27. Panagopoulos I, Gorunova L, Bjerkehagen B, Heim S (2014)
    The "grep" command but not FusionMap, FusionFinder or ChimeraScan captures the CIC-DUX4 fusion gene from whole transcriptome sequencing data on a small round cell tumor with t(4;19)(q35;q13)
    PLoS One, 9 (6), e99439
    DOI 10.1371/journal.pone.0099439, PubMed 24950227
  28. Panagopoulos I, Gorunova L, Davidson B, Heim S (2014)
    Novel TNS3-MAP3K3 and ZFPM2-ELF5 fusion genes identified by RNA sequencing in multicystic mesothelioma with t(7;17)(p12;q23) and t(8;11)(q23;p13)
    Cancer Lett, 357 (2), 502-9
    DOI 10.1016/j.canlet.2014.12.002, PubMed 25484136
  29. Panagopoulos I, Thorsen J, Gorunova L, Micci F, Heim S (2014)
    Sequential combination of karyotyping and RNA-sequencing in the search for cancer-specific fusion genes
    Int J Biochem Cell Biol, 53, 462-5
    DOI 10.1016/j.biocel.2014.05.018, PubMed 24863361
  30. Panagopoulos I, Torkildsen S, Gorunova L, Tierens A, Tjønnfjord GE, Heim S (2014)
    Comparison between karyotyping-FISH-reverse transcription PCR and RNA-sequencing-fusion gene identification programs in the detection of KAT6A-CREBBP in acute myeloid leukemia
    PLoS One, 9 (5), e96570
    DOI 10.1371/journal.pone.0096570, PubMed 24798186
  31. Paulsen J, Rødland EA, Holden L, Holden M, Hovig E (2014)
    A statistical model of ChIA-PET data for accurate detection of chromatin 3D interactions
    Nucleic Acids Res, 42 (18), e143
    DOI 10.1093/nar/gku738, PubMed 25114054
  32. Paulsen J, Sandve GK, Gundersen S, Lien TG, Trengereid K, Hovig E (2014)
    HiBrowse: multi-purpose statistical analysis of genome-wide chromatin 3D organization
    Bioinformatics, 30 (11), 1620-2
    DOI 10.1093/bioinformatics/btu082, PubMed 24511080
  33. Pujade-Lauraine E, Hilpert F, Weber B, Reuss A, Poveda A, Kristensen G, Sorio R, Vergote I, Witteveen P, Bamias A, Pereira D, Wimberger P, Oaknin A, Mirza MR, Follana P, Bollag D, Ray-Coquard I (2014)
    Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial
    J Clin Oncol, 32 (13), 1302-8
    DOI 10.1200/JCO.2013.51.4489, PubMed 24637997
  34. Sagae S, Susumu N, Viswanathan AN, Aoki D, Backes FJ, Provencher DM, Vaughan M, Creutzberg CL, Kurzeder C, Kristensen G, Lee C, Kurtz JE, Glasspool RM, Small W (2014)
    Gynecologic Cancer InterGroup (GCIG) consensus review for uterine serous carcinoma
    Int J Gynecol Cancer, 24 (9 Suppl 3), S83-9
    DOI 10.1097/IGC.0000000000000264, PubMed 25341586
  35. Sikkeland J, Jin Y, Saatcioglu F (2014)
    Methods to assess lipid accumulation in cancer cells
    Methods Enzymol, 542, 407-23
    DOI 10.1016/B978-0-12-416618-9.00021-2, PubMed 24862278
  36. Skårn M, Noordhuis P, Wang MY, Veuger M, Kresse SH, Egeland EV, Micci F, Namløs HM, Håkelien AM, Olafsrud SM, Lorenz S, Haraldsen G, Kvalheim G, Meza-Zepeda LA, Myklebost O (2014)
    Generation and characterization of an immortalized human mesenchymal stromal cell line
    Stem Cells Dev, 23 (19), 2377-89
    DOI 10.1089/scd.2013.0599, PubMed 24857590
  37. Smebye ML, Sveen A, Haugom L, Davidson B, Tropé CG, Lothe RA, Heim S, Skotheim RI, Micci F (2014)
    Chromosome 19 rearrangements in ovarian carcinomas: zinc finger genes are particularly targeted
    Genes Chromosomes Cancer, 53 (7), 558-67
    DOI 10.1002/gcc.22166, PubMed 24634323
  38. Sternemalm J, Russnes HG, Zhao X, Risberg B, Nord S, Caldas C, Børresen-Dale AL, Stokke T, Patzke S (2014)
    Nuclear CSPP1 expression defined subtypes of basal-like breast cancer
    Br J Cancer, 111 (2), 326-38
    DOI 10.1038/bjc.2014.297, PubMed 24901235
  39. Torsvik A, Stieber D, Enger PØ, Golebiewska A, Molven A, Svendsen A, Westermark B, Niclou SP, Olsen TK, Chekenya Enger M, Bjerkvig R (2014)
    U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells
    Cancer Med, 3 (4), 812-24
    DOI 10.1002/cam4.219, PubMed 24810477
  40. Wang L, Wenners A, Hilpert F, Fredrik R, Micci F, Onkes W, Caliebe A, Maass N, Weimer J, Arnold N (2014)
    Frequent translocations of 11q13.2 and 19p13.2 in ovarian cancer
    Genes Chromosomes Cancer, 53 (6), 447-53
    DOI 10.1002/gcc.22152, PubMed 24615723
  41. Wang Y, Herrstedt J, Havsteen H, DePoint Christensen R, Mirza MR, Lund B, Maenpaa J, Kristensen G (2014)
    A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer
    BMC Cancer, 14, 937
    DOI 10.1186/1471-2407-14-937, PubMed 25494701
  42. Wollen EJ, Kwinta P, Bik-Multanowski M, Madetko-Talowska A, Sejersted Y, Wright MS, Günther CC, Nygård S, Saugstad OD, Pietrzyk JJ (2014)
    Hypoxia-reoxygenation affects whole-genome expression in the newborn eye
    Invest Ophthalmol Vis Sci, 55 (3), 1393-401
    DOI 10.1167/iovs.13-13159, PubMed 24458145
  43. Wu X, Sagave J, Rutkovskiy A, Haugen F, Baysa A, Nygård S, Czibik G, Dahl CP, Gullestad L, Vaage J, Valen G (2014)
    Expression of bone morphogenetic protein 4 and its receptors in the remodeling heart
    Life Sci, 97 (2), 145-54
    DOI 10.1016/j.lfs.2013.12.030, PubMed 24398041

Publications 2013

  1. Andersen EK, Hole KH, Lund KV, Sundfør K, Kristensen GB, Lyng H, Malinen E (2013)
    Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome
    Radiother Oncol, 107 (1), 117-22
    DOI 10.1016/j.radonc.2012.11.007, PubMed 23333024
  2. Baumbusch LO, Helland Å, Wang Y, Liestøl K, Schaner ME, Holm R, Etemadmoghadam D, Alsop K, Brown P, Australian Ovarian Cancer Study Group, Mitchell G, Fereday S, DeFazio A, Bowtell DD, Kristensen GB, Lingjærde OC, Børresen-Dale AL (2013)
    High levels of genomic aberrations in serous ovarian cancers are associated with better survival
    PLoS One, 8 (1), e54356
    DOI 10.1371/journal.pone.0054356, PubMed 23372714
  3. Clancy T, Rødland EA, Nygard S, Hovig E (2013)
    Predicting physical interactions between protein complexes
    Mol Cell Proteomics, 12 (6), 1723-34
    DOI 10.1074/mcp.O112.019828, PubMed 23438732
  4. Davidson B, Abeler VM, Førsund M, Holth A, Yang Y, Kobayashi Y, Chen L, Kristensen GB, Shih IeM, Wang TL (2013)
    Gene expression signatures of primary and metastatic uterine leiomyosarcoma
    Hum Pathol, 45 (4), 691-700
    DOI 10.1016/j.humpath.2013.11.003, PubMed 24485798
  5. Domingo E, Ramamoorthy R, Oukrif D, Rosmarin D, Presz M, Wang H, Pulker H, Lockstone H, Hveem T, Cranston T, Danielsen H, Novelli M, Davidson B, Xu ZZ, Molloy P, Johnstone E, Holmes C, Midgley R, Kerr D, Sieber O, Tomlinson I (2013)
    Use of multivariate analysis to suggest a new molecular classification of colorectal cancer
    J Pathol, 229 (3), 441-8
    DOI 10.1002/path.4139, PubMed 23165447
  6. Fiskvik I, Aamot HV, Delabie J, Smeland EB, Stokke T, Heim S, Holte H (2013)
    Karyotyping of diffuse large B-cell lymphomas: loss of 17p is associated with poor patient outcome
    Eur J Haematol, 91 (4), 332-8
    DOI 10.1111/ejh.12171, PubMed 23859481
  7. Fromm B, Worren MM, Hahn C, Hovig E, Bachmann L (2013)
    Substantial loss of conserved and gain of novel MicroRNA families in flatworms
    Mol Biol Evol, 30 (12), 2619-28
    DOI 10.1093/molbev/mst155, PubMed 24025793
  8. Greimel E, Kristensen GB, van der Burg ME, Coronado P, Rustin G, del Rio AS, Reed NS, Nordal RR, Coens C, Vergote I, European Organization for Research and Treatment of Cancer - Gynaecological Cancer Group and NCIC Clinical Trials Group (2013)
    Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy
    Gynecol Oncol, 131 (2), 437-44
    DOI 10.1016/j.ygyno.2013.08.014, PubMed 23994107
  9. Haidry RJ, Butt MA, Dunn J, Banks M, Gupta A, Smart H, Bhandari P, Smith LA, Willert R, Fullarton G, John M, Di Pietro M, Penman I, Novelli M, Lovat LB (2013)
    Radiofrequency ablation for early oesophageal squamous neoplasia: outcomes form United Kingdom registry
    World J Gastroenterol, 19 (36), 6011-9
    DOI 10.3748/wjg.v19.i36.6011, PubMed 24106401
  10. Håvik AB, Lind GE, Honne H, Meling TR, Scheie D, Hall KS, van den Berg E, Mertens F, Picci P, Lothe RA, Heim S, Brandal P (2013)
    Sequencing IDH1/2 glioma mutation hotspots in gliomas and malignant peripheral nerve sheath tumors
    Neuro Oncol, 16 (2), 320-2
    DOI 10.1093/neuonc/not230, PubMed 24311631
  11. Jenstad M, Chaudhry FA (2013)
    The Amino Acid Transporters of the Glutamate/GABA-Glutamine Cycle and Their Impact on Insulin and Glucagon Secretion
    Front Endocrinol (Lausanne), 4, 199
    DOI 10.3389/fendo.2013.00199, PubMed 24427154
  12. Jin Y, Qu S, Tesikova M, Wang L, Kristian A, Mælandsmo GM, Kong H, Zhang T, Jerónimo C, Teixeira MR, Yuca E, Tekedereli I, Gorgulu K, Alpay N, Sood AK, Lopez-Berestein G, Danielsen HE, Ozpolat B, Saatcioglu F (2013)
    Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer
    Proc Natl Acad Sci U S A, 110 (28), E2572-81
    DOI 10.1073/pnas.1304318110, PubMed 23798432
  13. Kumar RP, Albregtsen F, Reimers M, Lango T, Edwin B, Elle OJ (2013)
    3D multiscale vessel enhancement based centerline extraction of blood vessels
    PROC SPIE, 8669, 86691X
  14. Kaarbø M, Storm ML, Qu S, Wæhre H, Risberg B, Danielsen HE, Saatcioglu F (2013)
    TCTP is an androgen-regulated gene implicated in prostate cancer
    PLoS One, 8 (7), e69398
    DOI 10.1371/journal.pone.0069398, PubMed 23894469
  15. Micci F, Panagopoulos I, Haugom L, Dahlback HS, Pretorius ME, Davidson B, Abeler VM, Tropé CG, Danielsen HE, Heim S (2013)
    Genomic aberration patterns and expression profiles of squamous cell carcinomas of the vulva
    Genes Chromosomes Cancer, 52 (6), 551-63
    DOI 10.1002/gcc.22053, PubMed 23404381
  16. Onkes W, Fredrik R, Micci F, Schönbeck BJ, Martin-Subero JI, Ullmann R, Hilpert F, Bräutigam K, Janssen O, Maass N, Siebert R, Heim S, Arnold N, Weimer J (2013)
    Breakpoint characterization of the der(19)t(11;19)(q13;p13) in the ovarian cancer cell line SKOV-3
    Genes Chromosomes Cancer, 52 (5), 512-22
    DOI 10.1002/gcc.22048, PubMed 23362175
  17. Onsrud M, Cvancarova M, Hellebust TP, Tropé CG, Kristensen GB, Lindemann K (2013)
    Long-term outcomes after pelvic radiation for early-stage endometrial cancer
    J Clin Oncol, 31 (31), 3951-6
    DOI 10.1200/JCO.2013.48.8023, PubMed 24019546
  18. Panagopoulos I, Gorunova L, Brandal P, Garnes M, Tierens A, Heim S (2013)
    Myeloid leukemia with t(7;21)(p22;q22) and 5q deletion
    Oncol Rep, 30 (4), 1549-52
    DOI 10.3892/or.2013.2623, PubMed 23877199
  19. Panagopoulos I, Gorunova L, Zeller B, Tierens A, Heim S (2013)
    Cryptic FUS-ERG fusion identified by RNA-sequencing in childhood acute myeloid leukemia
    Oncol Rep, 30 (6), 2587-92
    DOI 10.3892/or.2013.2751, PubMed 24068373
  20. Panagopoulos I, Micci F, Thorsen J, Haugom L, Buechner J, Kerndrup G, Tierens A, Zeller B, Heim S (2013)
    Fusion of ZMYND8 and RELA genes in acute erythroid leukemia
    PLoS One, 8 (5), e63663
    DOI 10.1371/journal.pone.0063663, PubMed 23667654
  21. Panagopoulos I, Thorsen J, Gorunova L, Haugom L, Bjerkehagen B, Davidson B, Heim S, Micci F (2013)
    Fusion of the ZC3H7B and BCOR genes in endometrial stromal sarcomas carrying an X;22-translocation
    Genes Chromosomes Cancer, 52 (7), 610-8
    DOI 10.1002/gcc.22057, PubMed 23580382
  22. Panagopoulos I, Thorsen J, Gorunova L, Micci F, Haugom L, Davidson B, Heim S (2013)
    RNA sequencing identifies fusion of the EWSR1 and YY1 genes in mesothelioma with t(14;22)(q32;q12)
    Genes Chromosomes Cancer, 52 (8), 733-40
    DOI 10.1002/gcc.22068, PubMed 23630070
  23. Paulsen J, Lien TG, Sandve GK, Holden L, Borgan O, Glad IK, Hovig E (2013)
    Handling realistic assumptions in hypothesis testing of 3D co-localization of genomic elements
    Nucleic Acids Res, 41 (10), 5164-74
    DOI 10.1093/nar/gkt227, PubMed 23571755
  24. Sandve GK, Gundersen S, Johansen M, Glad IK, Gunathasan K, Holden L, Holden M, Liestøl K, Nygård S, Nygaard V, Paulsen J, Rydbeck H, Trengereid K, Clancy T, Drabløs F, Ferkingstad E, Kalas M, Lien T, Rye MB, Frigessi A, Hovig E (2013)
    The Genomic HyperBrowser: an analysis web server for genome-scale data
    Nucleic Acids Res, 41 (Web Server issue), W133-41
    DOI 10.1093/nar/gkt342, PubMed 23632163
  25. Sandve GK, Nekrutenko A, Taylor J, Hovig E (2013)
    Ten simple rules for reproducible computational research
    PLoS Comput Biol, 9 (10), e1003285
    DOI 10.1371/journal.pcbi.1003285, PubMed 24204232
  26. Schee K, Lorenz S, Worren MM, Günther CC, Holden M, Hovig E, Fodstad O, Meza-Zepeda LA, Flatmark K (2013)
    Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer
    PLoS One, 8 (6), e66165
    DOI 10.1371/journal.pone.0066165, PubMed 23824282
  27. Stark D, Nankivell M, Pujade-Lauraine E, Kristensen G, Elit L, Stockler M, Hilpert F, Cervantes A, Brown J, Lanceley A, Velikova G, Sabate E, Pfisterer J, Carey MS, Beale P, Qian W, Swart AM, Oza A, Perren T (2013)
    Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial
    Lancet Oncol, 14 (3), 236-43
    DOI 10.1016/S1470-2045(12)70567-3, PubMed 23333117
  28. Vistnes M, Høiseth AD, Røsjø H, Nygård S, Pettersen E, Søyseth V, Hurlen P, Christensen G, Omland T (2013)
    Lack of pro-inflammatory cytokine mobilization predicts poor prognosis in patients with acute heart failure
    Cytokine, 61 (3), 962-9
    DOI 10.1016/j.cyto.2013.01.006, PubMed 23415671
  29. Wollen EJ, Sejersted Y, Wright MS, Bik-Multanowski M, Madetko-Talowska A, Günther CC, Nygård S, Kwinta P, Pietrzyk JJ, Saugstad OD (2013)
    Transcriptome profiling of the newborn mouse lung after hypoxia and reoxygenation: hyperoxic reoxygenation affects mTOR signaling pathway, DNA repair, and JNK-pathway regulation
    Pediatr Res, 74 (5), 536-44
    DOI 10.1038/pr.2013.140, PubMed 23999071
  30. Wollen EJ, Sejersted Y, Wright MS, Madetko-Talowska A, Bik-Multanowski M, Kwinta P, Günther CC, Nygård S, Løberg EM, Ystgaard MB, Pietrzyk JJ, Saugstad OD (2013)
    Transcriptome profiling of the newborn mouse brain after hypoxia-reoxygenation: hyperoxic reoxygenation induces inflammatory and energy failure responsive genes
    Pediatr Res, 75 (4), 517-26
    DOI 10.1038/pr.2013.249, PubMed 24375083
  31. Wæhre H, Vlatkovic L, Cvancarova M, Paus E, Fosså SD, Danielsen HE (2013)
    Fifteen-year mortality after radical prostatectomy: which factors are available for patient counselling?
    Scand J Urol, 48 (2), 123-30
    DOI 10.3109/21681805.2013.817483, PubMed 23885810

Publications 2012

  1. Barbany G, Andersen MK, Autio K, Borgström G, Franco LC, Golovleva I, Heim S, Heinonen K, Hovland R, Johansson B, Johannsson JH, Kjeldsen E, Nordgren A, Palmqvist L, Forestier E, Nordic Society of Paediatric Haematology and Oncology, Swedish Cytogenetic Leukaemia Study Group, NOPHO Leukaemia Cytogenetic Study Group (2012)
    Additional aberrations of the ETV6 and RUNX1 genes have no prognostic impact in 229 t(12;21)(p13;q22)-positive B-cell precursor acute lymphoblastic leukaemias treated according to the NOPHO-ALL-2000 protocol
    Leuk Res, 36 (7), 936-8
    DOI 10.1016/j.leukres.2012.03.024, PubMed 22521551
  2. Halle C, Andersen E, Lando M, Aarnes EK, Hasvold G, Holden M, Syljuåsen RG, Sundfør K, Kristensen GB, Holm R, Malinen E, Lyng H (2012)
    Hypoxia-induced gene expression in chemoradioresistant cervical cancer revealed by dynamic contrast-enhanced MRI
    Cancer Res, 72 (20), 5285-95
    DOI 10.1158/0008-5472.CAN-12-1085, PubMed 22890239
  3. Horgmo ØH, Danielsen HE (2012)
    A camera support for operating theatre videography
    J Vis Commun Med, 35 (1), 20-4
    DOI 10.3109/17453054.2012.656585, PubMed 22397480
  4. Håvik AB, Brandal P, Honne H, Dahlback HS, Scheie D, Hektoen M, Meling TR, Helseth E, Heim S, Lothe RA, Lind GE (2012)
    MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR
    J Transl Med, 10, 36
    DOI 10.1186/1479-5876-10-36, PubMed 22390413
  5. Kaye S, Aamdal S, Jones R, Freyer G, Pujade-Lauraine E, de Vries EG, Barriuso J, Sandhu S, Tan DS, Hartog V, Kuenen B, Ruijter R, Kristensen GB, Nyakas M, Barrett S, Burke W, Pietersma D, Stuart M, Emeribe U, Boven E (2012)
    Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours
    Br J Cancer, 106 (11), 1728-34
    DOI 10.1038/bjc.2012.158, PubMed 22531637
  6. Larsen HA, Austbø L, Mørkøre T, Thorsen J, Hordvik I, Fischer U, Jirillo E, Rimstad E, Koppang EO (2012)
    Pigment-producing granulomatous myopathy in Atlantic salmon: a novel inflammatory response
    Fish Shellfish Immunol, 33 (2), 277-85
    DOI 10.1016/j.fsi.2012.05.012, PubMed 22634154
  7. Lee CK, Simes RJ, Brown C, Gebski V, Pfisterer J, Swart AM, Berton-Rigaud D, Plante M, Skeie-Jensen T, Vergote I, Schauer C, Pisano C, Parma G, Baumann K, Ledermann JA, Pujade-Lauraine E, Bentley J, Kristensen G, Belau A, Nankivell M, Canzler U, Lord SJ, Kurzeder C, Friedlander M (2012)
    A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer
    Ann Oncol, 24 (4), 937-43
    DOI 10.1093/annonc/mds538, PubMed 23104722
  8. Lindemann K, Christensen RD, Vergote I, Stuart G, Izquierdo MA, Kærn J, Havsteen H, Eisenhauer E, Ridderheim M, Lopez AB, Hirte H, Aavall-Lundquvist E, Vrdoljak E, Green J, Kristensen GB (2012)
    First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)--a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG
    Ann Oncol, 23 (10), 2613-2619
    DOI 10.1093/annonc/mds060, PubMed 22539562
  9. Lindholm EM, Kristian A, Nalwoga H, Krüger K, Nygård S, Akslen LA, Mælandsmo GM, Engebraaten O (2012)
    Effect of antiangiogenic therapy on tumor growth, vasculature and kinase activity in basal- and luminal-like breast cancer xenografts
    Mol Oncol, 6 (4), 418-27
    DOI 10.1016/j.molonc.2012.03.006, PubMed 22521242
  10. Micci F, Thorsen J, Panagopoulos I, Nyquist KB, Zeller B, Tierens A, Heim S (2012)
    High-throughput sequencing identifies an NFIA/CBFA2T3 fusion gene in acute erythroid leukemia with t(1;16)(p31;q24)
    Leukemia, 27 (4), 980-2
    DOI 10.1038/leu.2012.266, PubMed 23032695
  11. Nielsen B, Albregtsen F, Danielsen HE (2012)
    Automatic segmentation of cell nuclei in Feulgen-stained histological sections of prostate cancer and quantitative evaluation of segmentation results
    Cytometry A, 81 (7), 588-601
    DOI 10.1002/cyto.a.22068, PubMed 22605528
  12. Nielsen B, Albregtsen F, Kildal W, Abeler VM, Kristensen GB, Danielsen HE (2012)
    The prognostic value of adaptive nuclear texture features from patient gray level entropy matrices in early stage ovarian cancer
    Anal Cell Pathol (Amst), 35 (4), 305-14
    DOI 10.3233/ACP-2012-0065, PubMed 22596183
  13. Nordstrand LM, Furu K, Paulsen J, Rognes T, Klungland A (2012)
    Alkbh1 and Tzfp repress a non-repeat piRNA cluster in pachytene spermatocytes
    Nucleic Acids Res, 40 (21), 10950-63
    DOI 10.1093/nar/gks839, PubMed 22965116
  14. Nyquist KB, Panagopoulos I, Thorsen J, Haugom L, Gorunova L, Bjerkehagen B, Fosså A, Guriby M, Nome T, Lothe RA, Skotheim RI, Heim S, Micci F (2012)
    Whole-transcriptome sequencing identifies novel IRF2BP2-CDX1 fusion gene brought about by translocation t(1;5)(q42;q32) in mesenchymal chondrosarcoma
    PLoS One, 7 (11), e49705
    DOI 10.1371/journal.pone.0049705, PubMed 23185413
  15. Nyquist KB, Panagopoulos I, Thorsen J, Roberto R, Wik HS, Tierens A, Heim S, Micci F (2012)
    t(12;13)(q14;q31) leading to HMGA2 upregulation in acute myeloid leukaemia
    Br J Haematol, 157 (6), 769-71
    DOI 10.1111/j.1365-2141.2012.09081.x, PubMed 22404713
  16. Panagopoulos I, Micci F, Thorsen J, Gorunova L, Eibak AM, Bjerkehagen B, Davidson B, Heim S (2012)
    Novel fusion of MYST/Esa1-associated factor 6 and PHF1 in endometrial stromal sarcoma
    PLoS One, 7 (6), e39354
    DOI 10.1371/journal.pone.0039354, PubMed 22761769
  17. Panagopoulos I, Micci F, Thorsen J, Haugom L, Tierens A, Ulvmoen A, Heim S (2012)
    A novel TCF3-HLF fusion transcript in acute lymphoblastic leukemia with a t(17;19)(q22;p13)
    Cancer Genet, 205 (12), 669-72
    DOI 10.1016/j.cancergen.2012.10.004, PubMed 23181981
  18. Pradhan M, Davidson B, Abeler VM, Danielsen HE, Tropé CG, Kristensen GB, Risberg BÅ (2012)
    DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometrium
    Virchows Arch, 461 (3), 291-8
    DOI 10.1007/s00428-012-1275-2, PubMed 22824999
  19. Pust S, Klokk TI, Musa N, Jenstad M, Risberg B, Erikstein B, Tcatchoff L, Liestøl K, Danielsen HE, van Deurs B, Sandvig K (2012)
    Flotillins as regulators of ErbB2 levels in breast cancer
    Oncogene, 32 (29), 3443-51
    DOI 10.1038/onc.2012.357, PubMed 22869152
  20. Røsjø H, Nygård S, Kaukonen KM, Karlsson S, Stridsberg M, Ruokonen E, Pettilä V, Omland T, FINNSEPSIS Study Group (2012)
    Prognostic value of chromogranin A in severe sepsis: data from the FINNSEPSIS study
    Intensive Care Med, 38 (5), 820-9
    DOI 10.1007/s00134-012-2546-8, PubMed 22491939
  21. Røsjø H, Tamm NN, Kravdal G, Seferian KR, Høiseth AD, Nygård S, Badr P, Røysland R, Omland T (2012)
    Diagnostic utility of a single-epitope sandwich B-type natriuretic peptide assay in stable coronary artery disease: data from the Akershus Cardiac Examination (ACE) 1 Study
    Clin Biochem, 45 (16-17), 1269-75
    DOI 10.1016/j.clinbiochem.2012.05.010, PubMed 22609895
  22. Røysland R, Kravdal G, Høiseth AD, Nygård S, Badr P, Hagve TA, Omland T, Røsjø H (2012)
    Cardiac troponin T levels and exercise stress testing in patients with suspected coronary artery disease: the Akershus Cardiac Examination (ACE) 1 study
    Clin Sci (Lond), 122 (12), 599-606
    DOI 10.1042/CS20110557, PubMed 22239123
  23. Skrbic B, Bjørnstad JL, Marstein HS, Carlson CR, Sjaastad I, Nygård S, Bjørnstad S, Christensen G, Tønnessen T (2012)
    Differential regulation of extracellular matrix constituents in myocardial remodeling with and without heart failure following pressure overload
    Matrix Biol, 32 (2), 133-42
    DOI 10.1016/j.matbio.2012.11.011, PubMed 23220517
  24. Thingnes J, Lavelle TJ, Gjuvsland AB, Omholt SW, Hovig E (2012)
    Towards a quantitative understanding of the MITF-PIAS3-STAT3 connection
    BMC Syst Biol, 6, 11
    DOI 10.1186/1752-0509-6-11, PubMed 22316093
  25. Thingnes J, Lavelle TJ, Hovig E, Omholt SW (2012)
    Understanding the melanocyte distribution in human epidermis: an agent-based computational model approach
    PLoS One, 7 (7), e40377
    DOI 10.1371/journal.pone.0040377, PubMed 22792296
  26. Thorsen J, Aamot HV, Roberto R, Tjønnfjord GE, Micci F, Heim S (2012)
    Myelodysplastic syndrome with a t(2;11)(p21;q23-24) and translocation breakpoint close to miR-125b-1
    Cancer Genet, 205 (10), 528-32
    DOI 10.1016/j.cancergen.2012.06.003, PubMed 22944560
  27. Tropé CG, Abeler VM, Kristensen GB (2012)
    Diagnosis and treatment of sarcoma of the uterus. A review
    Acta Oncol, 51 (6), 694-705
    DOI 10.3109/0284186X.2012.689111, PubMed 22793037
  28. Waehre A, Vistnes M, Sjaastad I, Nygård S, Husberg C, Lunde IG, Aukrust P, Yndestad A, Vinge LE, Behmen D, Neukamm C, Brun H, Thaulow E, Christensen G (2012)
    Chemokines regulate small leucine-rich proteoglycans in the extracellular matrix of the pressure-overloaded right ventricle
    J Appl Physiol (1985), 112 (8), 1372-82
    DOI 10.1152/japplphysiol.01350.2011, PubMed 22345433

Publications 2011

  1. Andersen EK, Hole KH, Lund KV, Sundfør K, Kristensen GB, Lyng H, Malinen E (2011)
    Dynamic contrast-enhanced MRI of cervical cancers: temporal percentile screening of contrast enhancement identifies parameters for prediction of chemoradioresistance
    Int J Radiat Oncol Biol Phys, 82 (3), e485-92
    DOI 10.1016/j.ijrobp.2011.05.050, PubMed 22014954
  2. Andersen MK, Autio K, Barbany G, Borgström G, Cavelier L, Golovleva I, Heim S, Heinonen K, Hovland R, Johannsson JH, Johansson B, Kjeldsen E, Nordgren A, Palmqvist L, Forestier E (2011)
    Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols
    Br J Haematol, 155 (2), 235-43
    DOI 10.1111/j.1365-2141.2011.08824.x, PubMed 21902680
  3. Bock AJ, Dong HP, Tropé CG, Staff AC, Risberg B, Davidson B (2011)
    Nucleoside transporters are widely expressed in ovarian carcinoma effusions
    Cancer Chemother Pharmacol, 69 (2), 467-75
    DOI 10.1007/s00280-011-1716-7, PubMed 21822668
  4. Bruhn S, Barrenäs F, Mobini R, Andersson BA, Chavali S, Egan BS, Hovig E, Sandve GK, Langston MA, Rogers G, Wang H, Benson M (2011)
    Increased expression of IRF4 and ETS1 in CD4+ cells from patients with intermittent allergic rhinitis
    Allergy, 67 (1), 33-40
    DOI 10.1111/j.1398-9995.2011.02707.x, PubMed 21919915
  5. Clancy T, Pedicini M, Castiglione F, Santoni D, Nygaard V, Lavelle TJ, Benson M, Hovig E (2011)
    Immunological network signatures of cancer progression and survival
    BMC Med Genomics, 4, 28
    DOI 10.1186/1755-8794-4-28, PubMed 21453479
  6. Dahlback HS, Brandal P, Gorunova L, Widing E, Meling TR, Krossnes BK, Heim S (2011)
    Genomic aberrations in pediatric gliomas and embryonal tumors
    Genes Chromosomes Cancer, 50 (10), 788-99
    DOI 10.1002/gcc.20898, PubMed 21717527
  7. Dahlback HS, Brandal P, Krossnes BK, Fric R, Meling TR, Meza-Zepeda LA, Danielsen HE, Heim S (2011)
    Multiple chromosomal monosomies are characteristic of giant cell ependymoma
    Hum Pathol, 42 (12), 2042-6
    DOI 10.1016/j.humpath.2011.02.012, PubMed 21683982
  8. Dahlback HS, Gorunova L, Brandal P, Scheie D, Helseth E, Meling TR, Heim S (2011)
    Genomic aberrations in diffuse low-grade gliomas
    Genes Chromosomes Cancer, 50 (6), 409-20
    DOI 10.1002/gcc.20866, PubMed 21412929
  9. Dahlback HS, Gorunova L, Micci F, Scheie D, Brandal P, Meling TR, Heim S (2011)
    Molecular cytogenetic analysis of a gliosarcoma with osseous metaplasia
    Cytogenet Genome Res, 134 (2), 88-95
    DOI 10.1159/000326804, PubMed 21555877
  10. Dong HP, Ree Rosnes AK, Bock AJ, Holth A, Flørenes VA, Trope' CG, Risberg B, Davidson B (2011)
    Flow cytometric measurement of cellular FLICE-inhibitory protein (c-FLIP) in ovarian carcinoma effusions
    Cytopathology, 22 (6), 373-82
    DOI 10.1111/j.1365-2303.2011.00929.x, PubMed 22032542
  11. Dunn JM, Hveem T, Pretorius M, Oukrif D, Nielsen B, Albregtsen F, Lovat LB, Novelli MR, Danielsen HE (2011)
    Comparison of nuclear texture analysis and image cytometric DNA analysis for the assessment of dysplasia in Barrett's oesophagus
    Br J Cancer, 105 (8), 1218-23
    DOI 10.1038/bjc.2011.353, PubMed 21934680
  12. Gorunova L, Bjerkehagen B, Heim S (2011)
    Paratesticular leiomyoma with a der(14)t(12;14)(q15;q24)
    Cancer Genet, 204 (8), 465-8
    DOI 10.1016/j.cancergen.2011.06.005, PubMed 21962898
  13. Gundersen S, Kalaš M, Abul O, Frigessi A, Hovig E, Sandve GK (2011)
    Identifying elemental genomic track types and representing them uniformly
    BMC Bioinformatics, 12, 494
    DOI 10.1186/1471-2105-12-494, PubMed 22208806
  14. Halle C, Lando M, Sundfør K, Kristensen GB, Holm R, Lyng H (2011)
    Phosphorylation of EGFR measured with in situ proximity ligation assay: relationship to EGFR protein level and gene dosage in cervical cancer
    Radiother Oncol, 101 (1), 152-7
    DOI 10.1016/j.radonc.2011.05.052, PubMed 21680035
  15. Kildal W, Micci F, Risberg B, Abeler VM, Kristensen GB, Heim S, Danielsen HE (2011)
    Genomic imbalances in endometrial adenocarcinomas - comparison of DNA ploidy, karyotyping and comparative genomic hybridization
    Mol Oncol, 6 (1), 98-107
    DOI 10.1016/j.molonc.2011.10.002, PubMed 22062770
  16. Kyriazoglou AI, Dimitriadis E, Arnogiannaki N, Brandal P, Heim S, Pandis N (2011)
    Similar cytogenetic findings in two synchronous secondary peripheral chondrosarcomas in a patient with multiple osteochondromas
    Cancer Genet, 204 (12), 677-81
    DOI 10.1016/j.cancergen.2011.10.013, PubMed 22285020
  17. Micci F, Thorsen J, Haugom L, Zeller B, Tierens A, Heim S (2011)
    Translocation t(1;16)(p31;q24) rearranging CBFA2T3 is specific for acute erythroid leukemia
    Leukemia, 25 (9), 1510-2
    DOI 10.1038/leu.2011.100, PubMed 21606959
  18. Nyquist KB, Thorsen J, Zeller B, Haaland A, Trøen G, Heim S, Micci F (2011)
    Identification of the TAF15-ZNF384 fusion gene in two new cases of acute lymphoblastic leukemia with a t(12;17)(p13;q12)
    Cancer Genet, 204 (3), 147-52
    DOI 10.1016/j.cancergen.2011.01.003, PubMed 21504714
  19. Perren TJ, Swart AM, Pfisterer J, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Kurzeder C, du Bois A, Sehouli J, Kimmig R, Stähle A, Collinson F, Essapen S, Gourley C, Lortholary A, Selle F, Mirza MR, Leminen A, Plante M, Stark D, Qian W, Parmar MK et al. (2011)
    A phase 3 trial of bevacizumab in ovarian cancer
    N Engl J Med, 365 (26), 2484-96
    DOI 10.1056/NEJMoa1103799, PubMed 22204725
  20. Pradhan M, Abeler VM, Danielsen HE, Sandstad B, Tropé CG, Kristensen GB, Risberg BÅ (2011)
    Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometrium
    Ann Oncol, 23 (5), 1178-1184
    DOI 10.1093/annonc/mdr368, PubMed 21965471
  21. Randen U, Yri OE, Tierens A, Heim S, Beiske K, Delabie J (2011)
    Mantle cell lymphoma with features of marginal-zone lymphoma
    J Hematop, 4 (1), 7-11
    DOI 10.1007/s12308-011-0084-x, PubMed 25089161
  22. Rustin GJ, Vergote I, Eisenhauer E, Pujade-Lauraine E, Quinn M, Thigpen T, du Bois A, Kristensen G, Jakobsen A, Sagae S, Greven K, Parmar M, Friedlander M, Cervantes A, Vermorken J, Gynecological Cancer Intergroup (2011)
    Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG)
    Int J Gynecol Cancer, 21 (2), 419-23
    DOI 10.1097/IGC.0b013e3182070f17, PubMed 21270624
  23. Sandve GK, Ferkingstad E, Nygård S (2011)
    Sequential Monte Carlo multiple testing
    Bioinformatics, 27 (23), 3235-41
    DOI 10.1093/bioinformatics/btr568, PubMed 21998154
  24. Sandve GK, Gundersen S, Rydbeck H, Glad IK, Holden L, Holden M, Liestøl K, Clancy T, Drabløs F, Ferkingstad E, Johansen M, Nygaard V, Tøstesen E, Frigessi A, Hovig E (2011)
    The differential disease regulome
    BMC Genomics, 12, 353
    DOI 10.1186/1471-2164-12-353, PubMed 21736759
  25. Star B, Nederbragt AJ, Jentoft S, Grimholt U, Malmstrøm M, Gregers TF, Rounge TB, Paulsen J, Solbakken MH, Sharma A, Wetten OF, Lanzén A, Winer R, Knight J, Vogel JH, Aken B, Andersen O, Lagesen K, Tooming-Klunderud A, Edvardsen RB, Tina KG, Espelund M, Nepal C, Previti C, Karlsen BO et al. (2011)
    The genome sequence of Atlantic cod reveals a unique immune system
    Nature, 477 (7363), 207-10
    DOI 10.1038/nature10342, PubMed 21832995
  26. Teixeira MR, Heim S (2011)
    Cytogenetic analysis of tumor clonality
    Adv Cancer Res, 112, 127-49
    DOI 10.1016/B978-0-12-387688-1.00005-3, PubMed 21925303
  27. Thorsen J, Micci F, Heim S (2011)
    Identification of chromosomal breakpoints of cancer-specific translocations by rolling circle amplification and long-distance inverse PCR
    Cancer Genet, 204 (8), 458-61
    DOI 10.1016/j.cancergen.2011.07.007, PubMed 21962896
  28. Vistad I, Cvancarova M, Kristensen GB, Fosså SD (2011)
    A study of chronic pelvic pain after radiotherapy in survivors of locally advanced cervical cancer
    J Cancer Surviv, 5 (2), 208-16
    DOI 10.1007/s11764-011-0172-z, PubMed 21259075
  29. Waehre A, Halvorsen B, Yndestad A, Husberg C, Sjaastad I, Nygård S, Dahl CP, Ahmed MS, Finsen AV, Reims H, Louch WE, Hilfiker-Kleiner D, Vinge LE, Roald B, Attramadal H, Lipp M, Gullestad L, Aukrust P, Christensen G (2011)
    Lack of chemokine signaling through CXCR5 causes increased mortality, ventricular dilatation and deranged matrix during cardiac pressure overload
    PLoS One, 6 (4), e18668
    DOI 10.1371/journal.pone.0018668, PubMed 21533157
  30. Warsame AA, Aasheim HC, Nustad K, Trøen G, Tierens A, Wang V, Randen U, Dong HP, Heim S, Brech A, Delabie J (2011)
    Splenic marginal zone lymphoma with VH1-02 gene rearrangement expresses poly- and self-reactive antibodies with similar reactivity
    Blood, 118 (12), 3331-9
    DOI 10.1182/blood-2011-03-341651, PubMed 21725051
  31. Ågesen TH, Berg M, Clancy T, Thiis-Evensen E, Cekaite L, Lind GE, Nesland JM, Bakka A, Mala T, Hauss HJ, Fetveit T, Vatn MH, Hovig E, Nesbakken A, Lothe RA, Skotheim RI (2011)
    CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancer
    Genes Immun, 12 (8), 653-62
    DOI 10.1038/gene.2011.43, PubMed 21716316

Publications 2010

  1. Athanasiu L, Mattingsdal M, Kähler AK, Brown A, Gustafsson O, Agartz I, Giegling I, Muglia P, Cichon S, Rietschel M, Pietiläinen OP, Peltonen L, Bramon E, Collier D, Clair DS, Sigurdsson E, Petursson H, Rujescu D, Melle I, Steen VM, Djurovic S, Andreassen OA (2010)
    Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort
    J Psychiatr Res, 44 (12), 748-53
    DOI 10.1016/j.jpsychires.2010.02.002, PubMed 20185149
  2. Brandal P, Teixeira MR, Heim S (2010)
    Genotypic and phenotypic classification of cancer: How should the impact of the two diagnostic approaches best be balanced?
    Genes Chromosomes Cancer, 49 (9), 763-74
    DOI 10.1002/gcc.20792, PubMed 20607708
  3. Dong HP, Holth A, Ruud MG, Emilsen E, Risberg B, Davidson B (2010)
    Measurement of apoptosis in cytological specimens by flow cytometry: comparison of Annexin V, caspase cleavage and dUTP incorporation assays
    Cytopathology, 22 (6), 365-72
    DOI 10.1111/j.1365-2303.2010.00811.x, PubMed 21054589
  4. du Bois A, Herrstedt J, Hardy-Bessard AC, Müller HH, Harter P, Kristensen G, Joly F, Huober J, Avall-Lundqvist E, Weber B, Kurzeder C, Jelic S, Pujade-Lauraine E, Burges A, Pfisterer J, Gropp M, Staehle A, Wimberger P, Jackisch C, Sehouli J (2010)
    Phase III trial of carboplatin plus paclitaxel with or without gemcitabine in first-line treatment of epithelial ovarian cancer
    J Clin Oncol, 28 (27), 4162-9
    DOI 10.1200/JCO.2009.27.4696, PubMed 20733132
  5. Eide MB, Liestøl K, Lingjaerde OC, Hystad ME, Kresse SH, Meza-Zepeda L, Myklebost O, Trøen G, Aamot HV, Holte H, Smeland EB, Delabie J (2010)
    Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones
    Blood, 116 (9), 1489-97
    DOI 10.1182/blood-2010-03-272278, PubMed 20505157
  6. Hogberg T, Signorelli M, de Oliveira CF, Fossati R, Lissoni AA, Sorbe B, Andersson H, Grenman S, Lundgren C, Rosenberg P, Boman K, Tholander B, Scambia G, Reed N, Cormio G, Tognon G, Clarke J, Sawicki T, Zola P, Kristensen G (2010)
    Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies
    Eur J Cancer, 46 (13), 2422-31
    DOI 10.1016/j.ejca.2010.06.002, PubMed 20619634
  7. Hougen K, Aronsen JM, Stokke MK, Enger U, Nygard S, Andersson KB, Christensen G, Sejersted OM, Sjaastad I (2010)
    Cre-loxP DNA recombination is possible with only minimal unspecific transcriptional changes and without cardiomyopathy in Tg(alphaMHC-MerCreMer) mice
    Am J Physiol Heart Circ Physiol, 299 (5), H1671-8
    DOI 10.1152/ajpheart.01155.2009, PubMed 20802136
  8. Micci F, Haugom L, Ahlquist T, Andersen HK, Abeler VM, Davidson B, Trope CG, Lothe RA, Heim S (2010)
    Genomic aberrations in borderline ovarian tumors
    J Transl Med, 8, 21
    DOI 10.1186/1479-5876-8-21, PubMed 20184781
  9. Micci F, Skotheim RI, Haugom L, Weimer J, Eibak AM, Abeler VM, Trope CG, Arnold N, Lothe RA, Heim S (2010)
    Array-CGH analysis of microdissected chromosome 19 markers in ovarian carcinoma identifies candidate target genes
    Genes Chromosomes Cancer, 49 (11), 1046-53
    DOI 10.1002/gcc.20813, PubMed 20725991
  10. Nakken S, Rødland EA, Hovig E (2010)
    Impact of DNA physical properties on local sequence bias of human mutation
    Hum Mutat, 31 (12), 1316-25
    DOI 10.1002/humu.21371, PubMed 20886615
  11. Pedicini M, Barrenäs F, Clancy T, Castiglione F, Hovig E, Kanduri K, Santoni D, Benson M (2010)
    Combining network modeling and gene expression microarray analysis to explore the dynamics of Th1 and Th2 cell regulation
    PLoS Comput Biol, 6 (12), e1001032
    DOI 10.1371/journal.pcbi.1001032, PubMed 21187905
  12. Pradhan M, Abeler VM, Davidson B, Kildal W, Nybøen A, Tropé CG, Risberg B, Danielsen HE (2010)
    DNA ploidy heterogeneity in endometrial carcinoma: comparison between curettage and hysterectomy specimens
    Int J Gynecol Pathol, 29 (6), 572-8
    DOI 10.1097/PGP.0b013e3181e2e8ee, PubMed 20881853
  13. Pradhan M, Risberg BA, Tropé CG, van de Rijn M, Gilks CB, Lee CH (2010)
    Gross genomic alterations and gene expression profiles of high- grade serous carcinoma of the ovary with and without BRCA1 inactivation
    BMC Cancer, 10, 493
    DOI 10.1186/1471-2407-10-493, PubMed 20843305
  14. Pujade-Lauraine E, Wagner U, Aavall-Lundqvist E, Gebski V, Heywood M, Vasey PA, Volgger B, Vergote I, Pignata S, Ferrero A, Sehouli J, Lortholary A, Kristensen G, Jackisch C, Joly F, Brown C, Le Fur N, du Bois A (2010)
    Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse
    J Clin Oncol, 28 (20), 3323-9
    DOI 10.1200/JCO.2009.25.7519, PubMed 20498395
  15. Rustin GJ, van der Burg ME, Griffin CL, Guthrie D, Lamont A, Jayson GC, Kristensen G, Mediola C, Coens C, Qian W, Parmar MK, Swart AM, MRC OV05, EORTC 55955 investigators (2010)
    Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial
    Lancet, 376 (9747), 1155-63
    DOI 10.1016/S0140-6736(10)61268-8, PubMed 20888993
  16. Sandve GK, Gundersen S, Rydbeck H, Glad IK, Holden L, Holden M, Liestøl K, Clancy T, Ferkingstad E, Johansen M, Nygaard V, Tøstesen E, Frigessi A, Hovig E (2010)
    The Genomic HyperBrowser: inferential genomics at the sequence level
    Genome Biol, 11 (12), R121
    DOI 10.1186/gb-2010-11-12-r121, PubMed 21182759
  17. Tropé CG, Kristensen GB (2010)
    The treatment of recurrent cervical cancer
    CME Journal of Gynecologic Oncology, 15 (1), 72-90
    PublikaID 106
  18. Tropé CG, Kristensen GB (2010)
    Surgery in treatment of recurrent cervical cancer
    CME Journal of Gynecologic Oncology, 15 (1), 33-39
    PublikaID 104
  19. Vergote I, Tropé CG, Amant F, Kristensen GB, Ehlen T, Johnson N, Verheijen RH, van der Burg ME, Lacave AJ, Panici PB, Kenter GG, Casado A, Mendiola C, Coens C, Verleye L, Stuart GC, Pecorelli S, Reed NS, European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group, NCIC Clinical Trials Group (2010)
    Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer
    N Engl J Med, 363 (10), 943-53
    DOI 10.1056/NEJMoa0908806, PubMed 20818904
  20. Verleye L, Ottevanger PB, Kristensen GB, Ehlen T, Johnson N, van der Burg ME, Reed NS, Verheijen RH, Gaarenstroom KN, Mosgaard B, Seoane JM, van der Velden J, Lotocki R, van der Graaf W, Penninckx B, Coens C, Stuart G, Vergote I (2010)
    Quality of pathology reports for advanced ovarian cancer: are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trial
    Eur J Cancer, 47 (1), 57-64
    DOI 10.1016/j.ejca.2010.08.008, PubMed 20850296
  21. Wang L, Jin Y, Arnoldussen YJ, Jonson I, Qu S, Maelandsmo GM, Kristian A, Risberg B, Waehre H, Danielsen HE, Saatcioglu F (2010)
    STAMP1 is both a proliferative and an antiapoptotic factor in prostate cancer
    Cancer Res, 70 (14), 5818-28
    DOI 10.1158/0008-5472.CAN-09-4697, PubMed 20587517

Publications 2009

  1. Abeler VM, Røyne O, Thoresen S, Danielsen HE, Nesland JM, Kristensen GB (2009)
    Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients
    Histopathology, 54 (3), 355-64
    DOI 10.1111/j.1365-2559.2009.03231.x, PubMed 19236512
  2. Bondi J, Pretorius M, Bukholm I, Danielsen H (2009)
    Large-scale genomic instability in colon adenocarcinomas and correlation with patient outcome
    APMIS, 117 (10), 730-6
    DOI 10.1111/j.1600-0463.2009.02527.x, PubMed 19775341
  3. Brekke HR, Kolberg M, Skotheim RI, Hall KS, Bjerkehagen B, Risberg B, Domanski HA, Mandahl N, Liestøl K, Smeland S, Danielsen HE, Mertens F, Lothe RA (2009)
    Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors
    Neuro Oncol, 11 (5), 514-28
    DOI 10.1215/15228517-2008-127, PubMed 19182148
  4. Cekaite L, Hovig E, Sioud M (2009)
    Monitoring B cell response to immunoselected phage-displayed peptides by microarrays
    Methods Mol Biol, 524, 273-85
    DOI 10.1007/978-1-59745-450-6_20, PubMed 19377952
  5. Dong HP, Holth A, Kleinberg L, Ruud MG, Elstrand MB, Tropé CG, Davidson B, Risberg B (2009)
    Evaluation of cell surface expression of phosphatidylserine in ovarian carcinoma effusions using the annexin-V/7-AAD assay: clinical relevance and comparison with other apoptosis parameters
    Am J Clin Pathol, 132 (5), 756-62
    DOI 10.1309/AJCPAVFA8J3KHPRS, PubMed 19846818
  6. Hellebust TP, Kristensen GB, Olsen DR (2009)
    Late effects after radiotherapy for locally advanced cervical cancer: comparison of two brachytherapy schedules and effect of dose delivered weekly
    Int J Radiat Oncol Biol Phys, 76 (3), 713-8
    DOI 10.1016/j.ijrobp.2009.02.024, PubMed 19427739
  7. Holm R, Ali T, Svendsrud DH, Nesland JM, Kristensen GB, Lyng H (2009)
    Expression of 14-3-3sigma in cervical squamous cell carcinomas: relationship with clinical outcome
    Oncol Rep, 22 (1), 11-5
    DOI 10.3892/or_00000399, PubMed 19513498
  8. Kildal W, Abeler VM, Kristensen GB, Jenstad M, Thoresen SØ, Danielsen HE (2009)
    The prognostic value of DNA ploidy in a total population of uterine sarcomas
    Ann Oncol, 20 (6), 1037-41
    DOI 10.1093/annonc/mdn765, PubMed 19201782
  9. Kildal W, Pradhan M, Abeler VM, Kristensen GB, Danielsen HE (2009)
    Beta-catenin expression in uterine sarcomas and its relation to clinicopathological parameters
    Eur J Cancer, 45 (13), 2412-7
    DOI 10.1016/j.ejca.2009.06.017, PubMed 19622417
  10. Nakken S, Rognes T, Hovig E (2009)
    The disruptive positions in human G-quadruplex motifs are less polymorphic and more conserved than their neutral counterparts
    Nucleic Acids Res, 37 (17), 5749-56
    DOI 10.1093/nar/gkp590, PubMed 19617376
  11. Nakken S, Rødland EA, Rognes T, Hovig E (2009)
    Large-scale inference of the point mutational spectrum in human segmental duplications
    BMC Genomics, 10, 43
    DOI 10.1186/1471-2164-10-43, PubMed 19161616
  12. Pradhan M, Davidson B, Tropé CG, Danielsen HE, Abeler VM, Risberg B (2009)
    Gross genomic alterations differ between serous borderline tumors and serous adenocarcinomas--an image cytometric DNA ploidy analysis of 307 cases with histogenetic implications
    Virchows Arch, 454 (6), 677-83
    DOI 10.1007/s00428-009-0778-y, PubMed 19421773
  13. Pretorius ME, Waehre H, Abeler VM, Davidson B, Vlatkovic L, Lothe RA, Giercksky KE, Danielsen HE (2009)
    Large scale genomic instability as an additive prognostic marker in early prostate cancer
    Cell Oncol, 31 (4), 251-9
    DOI 10.3233/CLO-2009-0463, PubMed 19633362
  14. Santos J, Cerveira N, Bizarro S, Ribeiro FR, Correia C, Torres L, Lisboa S, Vieira J, Mariz JM, Norton L, Snijder S, Mellink CH, Buijs A, Shih LY, Strehl S, Micci F, Heim S, Teixeira MR (2009)
    Expression pattern of the septin gene family in acute myeloid leukemias with and without MLL-SEPT fusion genes
    Leuk Res, 34 (5), 615-21
    DOI 10.1016/j.leukres.2009.08.018, PubMed 19748670
  15. Thingnes J, Oyehaug L, Hovig E, Omholt SW (2009)
    The mathematics of tanning
    BMC Syst Biol, 3, 60
    DOI 10.1186/1752-0509-3-60, PubMed 19505344
  16. Wangensteen T, Kolsgaard ML, Mattingsdal M, Joner G, Tonstad S, Undlien D, Retterstol L (2009)
    Mutations in the melanocortin 4 receptor (MC4R) gene in obese patients in Norway
    Exp Clin Endocrinol Diabetes, 117 (6), 266-73
    DOI 10.1055/s-0028-1102942, PubMed 19301229

Publications 2008

  1. Arnoldussen YJ, Lorenzo PI, Pretorius ME, Waehre H, Risberg B, Maelandsmo GM, Danielsen HE, Saatcioglu F (2008)
    The mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer
    Cancer Res, 68 (22), 9255-64
    DOI 10.1158/0008-5472.CAN-08-1224, PubMed 19010898
  2. Cerveira N, Micci F, Santos J, Pinheiro M, Correia C, Lisboa S, Bizarro S, Norton L, Glomstein A, Asberg AE, Heim S, Teixeira MR (2008)
    Molecular characterization of the MLL-SEPT6 fusion gene in acute myeloid leukemia: identification of novel fusion transcripts and cloning of genomic breakpoint junctions
    Haematologica, 93 (7), 1076-80
    DOI 10.3324/haematol.12594, PubMed 18492691
  3. Kleinberg L, Pradhan M, Tropé CG, Nesland JM, Davidson B, Risberg B (2008)
    Ovarian carcinoma cells in effusions show increased S-phase fraction compared to corresponding primary tumors
    Diagn Cytopathol, 36 (9), 637-44
    DOI 10.1002/dc.20879, PubMed 18677760
  4. Micci F, Haugom L, Abeler VM, Tropé CG, Danielsen HE, Heim S (2008)
    Consistent numerical chromosome aberrations in thecofibromas of the ovary
    Virchows Arch, 452 (3), 269-76
    DOI 10.1007/s00428-007-0561-x, PubMed 18188592
  5. Nygaard V, Liu F, Holden M, Kuo WP, Trimarchi J, Ohno-Machado L, Cepko CL, Frigessi A, Glad IK, Wiel MA, Hovig E, Lyng H (2008)
    Validation of oligoarrays for quantitative exploration of the transcriptome
    BMC Genomics, 9, 258
    DOI 10.1186/1471-2164-9-258, PubMed 18513391
  6. Ranheim T, Mattingsdal M, Lindvall JM, Holla OL, Berge KE, Kulseth MA, Leren TP (2008)
    Genome-wide expression analysis of cells expressing gain of function mutant D374Y-PCSK9
    J Cell Physiol, 217 (2), 459-67
    DOI 10.1002/jcp.21519, PubMed 18570182
  7. Rødland EK, Mattingsdal M, Olstad OK, Ovstebø R, Kierulf P, Muller F, Frøland SS (2008)
    Expression of genes in normal human monocytes in response to Aspergillus fumigatus
    Med Mycol, 46 (4), 327-36
    DOI 10.1080/13693780701874507, PubMed 18415839
  8. Tøstesen E, Sandve GK, Liu F, Hovig E (2008)
    Segmentation of DNA sequences into twostate regions and melting fork regions
    J Phys Condens Matter, 21 (3), 034109
    DOI 10.1088/0953-8984/21/3/034109, PubMed 21817254
  9. Vistad I, Cvancarova M, Fosså SD, Kristensen GB (2008)
    Postradiotherapy morbidity in long-term survivors after locally advanced cervical cancer: how well do physicians' assessments agree with those of their patients?
    Int J Radiat Oncol Biol Phys, 71 (5), 1335-42
    DOI 10.1016/j.ijrobp.2007.12.030, PubMed 18355976
  10. Vistad I, Kristensen GB, Fosså SD, Dahl AA, Mørkrid L (2008)
    Intestinal malabsorption in long-term survivors of cervical cancer treated with radiotherapy
    Int J Radiat Oncol Biol Phys, 73 (4), 1141-7
    DOI 10.1016/j.ijrobp.2008.05.064, PubMed 18760883

Publications 2007

  1. Klokk TI, Kilander A, Xi Z, Waehre H, Risberg B, Danielsen HE, Saatcioglu F (2007)
    Kallikrein 4 is a proliferative factor that is overexpressed in prostate cancer
    Cancer Res, 67 (11), 5221-30
    DOI 10.1158/0008-5472.CAN-06-4728, PubMed 17545602
  2. Liu F, Jenssen TK, Trimarchi J, Punzo C, Cepko CL, Ohno-Machado L, Hovig E, Kuo WP (2007)
    Comparison of hybridization-based and sequencing-based gene expression technologies on biological replicates
    BMC Genomics, 8, 153
    DOI 10.1186/1471-2164-8-153, PubMed 17555589
  3. Micci F, Heim S (2007)
    Pathogenetic mechanisms in endometrial stromal sarcoma
    Cytogenet Genome Res, 118 (2-4), 190-5
    DOI 10.1159/000108300, PubMed 18000370
  4. Pradhan M, Abeler VM, Danielsen HE, Risberg B (2007)
    A distinct pattern in the DNA ploidy histograms of hydatidiform moles and nonmolar abortuses is caused by accumulation of trophoblasts in the late s-phase
    Int J Gynecol Pathol, 26 (4), 432-6
    DOI 10.1097/pgp.0b013e31803c7c2e, PubMed 17885494
  5. Sudbo J, Bryne M, Mao L, Lotan R, Reith A, Kildal W, Davidson B, Soland TM, Lippman SM (2007)
    Molecular based treatment of oral cancer (Retraction of vol 39, pg 749, 2003)
    Oral Oncol., 43 (4), 421
  6. Sudbo J, Ried T, Bryne M, Kildal W, Danielsen H, Reith A (2007)
    Abnormal DNA content predicts the occurrence of carcinomas in non-dysplastic oral white patches (Retraction of vol 37, pg 558, 2001)
    Oral Oncol., 43 (4), 418
  7. Sudbo J, Ristimaki A, Sondresen JE, Kildal W, Boysen M, Koppang HS, Reith A, Risberg B, Nesland JM, Bryne M (2007)
    Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions (Retraction of vol 39, pg 497, 2003)
    Oral Oncol., 43 (4), 420
  8. Wang Y, Kristensen GB, Børresen-Dale AL, Helland A (2007)
    TP53 mutations and codon 72 genotype--impact on survival among ovarian cancer patients
    Ann Oncol, 18 (5), 964-6
    DOI 10.1093/annonc/mdm134, PubMed 17488735

Publications 2006

  1. Berner JM, Muller CR, Holden M, Wang J, Hovig E, Myklebost O (2006)
    Sampling effects on gene expression data from a human tumour xenograft
    Scand. J. Lab. Anim. Sci., 33 (1), 17-30
  2. Brandal P, Lie AK, Bassarova A, Svindland A, Risberg B, Danielsen H, Heim S (2006)
    Genomic aberrations in mucinous tubular and spindle cell renal cell carcinomas
    Mod Pathol, 19 (2), 186-94
    DOI 10.1038/modpathol.3800499, PubMed 16258504
  3. Lyng H, Brøvig RS, Svendsrud DH, Holm R, Kaalhus O, Knutstad K, Oksefjell H, Sundfør K, Kristensen GB, Stokke T (2006)
    Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer
    BMC Genomics, 7, 268
    DOI 10.1186/1471-2164-7-268, PubMed 17054779
  4. Nielsen B, Danielsen HE (2006)
    Prognostic value of adaptive textural features--the effect of standardizing nuclear first-order gray level statistics and mixing information from nuclei having different area
    Cell Oncol, 28 (3), 85-95
    DOI 10.1155/2006/370173, PubMed 16823177
  5. Nielsen B, Danielsen HE (2006)
    Prognostic value of adaptive textural features - The effect of standardizing nuclear first-order gray level statistics and mixing information from nuclei having different area
    Cell. Oncol., 28 (3), 85-95
  6. Pradhan M, Abeler VM, Danielsen HE, Tropé CG, Risberg BA (2006)
    Image cytometry DNA ploidy correlates with histological subtypes in endometrial carcinomas
    Mod Pathol, 19 (9), 1227-35
    DOI 10.1038/modpathol.3800641, PubMed 16729014
 
Page visits: 8466